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ABSTRACT: A visible-light-mediated annulation of N-sulfonylallylamines and olefins is reported. Rapid access to highly func-
tionalized chloromethylated pyrrolidines can be achieved using mild conditions for the generation of nitrogen-centered radicals. 
Both a transition metal based catalyst and an organic dye can be used as photosensitizers, with 0.5 mol% loading. The reaction was 
found to be applicable to a large variety of electron-rich/electron-neutral olefins. 
INTRODUCTION 
In recent years, there has been increasing interest in the 
medicinal chemistry community in moving away from flat 
motifs towards 3D scaffolds, typically aliphatic 
heterocycles.
1
 Pyrrolidines are prevalent in many 
biologically active natural products and pharmaceutical 
drug candidates
2 
and are of significant interest as scaffolds 
in drug discovery. Additionally, they are widely used in 
organic synthesis as organocatalysts and ligands
3
 (Scheme 
1). 
Scheme 1. Natural products and drugs containing pyrroli-
dine rings 
 
Due to the ubiquity and importance of these structures, 
the pyrrolidine scaffold has been the target of numerous 
synthetic efforts. The [3+2] cycloaddition with azomethine 
ylides and electron-deficient olefins is one of the most 
widely used methods for the construction of functionalized 
pyrrolidines
4
 (Scheme 2 (A)) while methods using radical 
species were until recently largely neglected.
5
 Indeed, the 
use of radical initiators, high reaction temperature or high-
energy ultraviolet (UV) photolysis presented limitations 
such as low functional group compatibility, substrate scope 
or practicability. However, due to renewed interest in 
photochemistry using visible-light mediated 
electron/energy transfer chemistry,
6
 the use of radical 
species has increased dramatically and led to the 
development of methods for pyrrolidine preparation 
utilizing different bond disconnections.
7 
These approaches 
are of significant interest as they bring more diversity to the 
substitution pattern of pyrrolidines by using electron-rich 
olefins as coupling partners. Indeed, they represent a 
complementary method to the classical [3+2] 
cycloaddition, which almost exclusively utilizes electron-
poor olefins.
4f
  
A recent example of the use of radical cation species via 
photoredox catalysis to form C-N bonds through intra- or 
intermolecular hydroamination of alkenes has been 
described by the group of Nicewicz; however the scope for 
the intermolecular approach was limited to four examples 
(Scheme 2 (B)).
8
 A promising, yet less studied strategy, is 
the use of nitrogen-centered radicals which have the 
potential to be powerful tools for the construction of C-N 
bonds (Scheme 2 (C)).
9
 These nitrogen-centered radicals 
can be accessed by the reductive cleavage of the relatively 
weak N-X bond (X = Cl, Br, I, N, O, S) or by the oxidative 
cleavage of N-H bonds. Traditionally prepared using harsh 
conditions such as radical initiators or UV-irradiation, 
recent developments in the field of visible-light 
photocatalysis have enabled their generation to be carried 
 out in a milder and selective way. The pathway using the 
oxidative scission of N-H bonds has been applied by 
Knowles in a photoredox protocol for intramolecular olefin 
hydroamination, giving access to diverse pyrrolidines with 
moderate diastereoselectivity.
10
 In parallel, the generation 
of nitrogen-centered radicals using N-halo compounds was 
carried out by the groups of Muñiz and Yu through the use 
of halogen-photoredox-catalysis for an intramolecular C-H 
amination Hofmann-Löffler-type reaction.
11
 
Scheme 2. Current approaches for the preparation of pyr-
rolidines 
 
N-halo substrates have also found applications for the 
construction of N-aryl bonds using visible light.
12
 Likewise, 
if the preparation of pyrrolidines (and piperidines) was 
described recently via aminohalogenation of olefins with 
aminyl radical using copper-catalyzed N-X activation or 
NIS-promoted aminocyclization,
13
 although no reactions 
using visible-light-mediated have been reported so far. 
More particularly, the intermolecular version of the radical 
amination remains a significant challenge due to the 
propensity of nitrogen-centered radicals to undergo 
competitive hydrogen abstraction. The intermolecular 
version was only studied using a radical initiator by the 
group of Oshima
5a
 (Scheme 3) while one isolated example 
reported by Yu showed that it was possible to perform 
chloramination of olefins with N-chlorosulfonamide under 
visible-light-promoted conditions.
14 
 
With the aim of using conditions involving visible-light 
for the preparation of pyrrolidines, we decided to 
investigate the annulation of olefins with N-haloallylamines 
(Scheme 3). We believed this approach would offer the 
advantage of milder reaction conditions and better 
functional group tolerance, allowing broader variations on 
the substitution pattern of the pyrrolidine scaffold. The 
challenging intermolecular strategy would allow access to 
complex pyrrolidines from simple and readily available 
starting materials. 
 
The N-halo partner 2 could be prepared 
via in situ halogenation of the corresponding free amine 1 
and would serve as both nitrogen and chlorine sources. 
Electron-neutral and electron-rich alkenes (which are 
typically unreactive toward the classical [3+2] 
cycloaddition) would be suitable partners as nitrogen-
centered radicals are electron deficient species. Transfer of 
the halogen atom from the nitrogen to the carbon of the 4-
position would also allow the possibility of further 
functionalization of the heterocycle. 
Scheme 3. Proposed visible-light-promoted annulation of 
N-haloallylamines with olefins 
 
 
RESULTS AND DISCUSSION 
As a starting point, our investigation focused on the 
formation of N-chloroallylamine from the corresponding 
NH-allylamine. N-Cl species have been preferentially used 
to generate related N-radicals owing to their ease of 
preparation and their high stability compared to the N-Br or 
N-I analogues. In order to avoid the isolation of the N-
chloro-intermediates, an in situ protocol was envisaged, 
allowing the formation of the pyrrolidines 4 in a one-pot 
procedure starting directly from the readily available 
allylamine 1. The N-tosylallylamine 1a was chosen for the 
optimization as it had previously demonstrated the best 
results using radical initiators for the generation of the 
radical species.
5a
 The optimal conditions for the N-
chlorination of 1a to form the intermediate 2a were 
established to be using 1,3-dichoro-5,5′-dimethylhydantoin 
as the chlorinating reagent in CH2Cl2 (0.2 M) at rt for 2 h, 
with 99% yield. A one-pot procedure was then 
investigated, where only two equivalents of the alkene 
partner were required to observe complete conversion 
(Table 1). Visible-light irradiation (blue LEDs – 450 nm) 
was found to be crucial for the reaction to proceed (Table 
1, entry 1) while the use of a photocatalyst was not 
mandatory in the first instance (Table 1, entry 2).  
 
 
 Table 1. Optimization of the annulation of NH-tosylallylamine 1a and styrene 
 
entry photocatalyst  (mol%) visible-light 
[CH2Cl2] 
(mol/L) 
temperature 
(°C) 
reaction time 
(h) 
yielda 
(%) 
1 - - 0.2 35 48 0b 
2 - blue LEDs  0.2 35 24 58 
3 - blue LEDs 0.2 55 24 80c 
4 - blue LEDs 0.2 55 1 12d 
5 Ir(dF(CF3)ppy)2(bpy)PF6 (0.5) blue LEDs 0.2 35 1 70 
6 Ir(dF(CF3)ppy)2(bpy)PF6 (0.5) blue LEDs 0.05 35 1 91 
7 fac-Ir(ppy)3 (0.5) blue LEDs 0.05 35 1 /
e 
8 Ru(bpy)3(PF6)2 (0.5) blue LEDs 0.05 35 1 39 
9 eosin Y (0.5) green LEDs 0.05 35 1 <5d 
10 fluorescein (0.5) blue LEDs 0.05 35 1 <5d 
11 4CzlPN (0.5) blue LEDs 0.05 35 1 79 
12 TPT (0.5) blue LEDs 0.05 35 1 28d 
13 CAT-1 (0.5) blue LEDs 0.05 35 1 71 
14 CAT-2 (0.5) blue LEDs 0.05 35 1 68 
15 CAT-3 (0.5) blue LEDs 0.05 35 1 61 
16 CAT-4 (0.5) blue LEDs 0.05 35 1 86 
aIsolated yields reported unless stated otherwise. bNo reaction. cPartial decomposition observed. dPercentage conversion of starting ma-
terial observed by 1H NMR.  eStarting material consumed, unknown products observed by 1H NMR. 
This suggests the reaction may not take place through a 
photoredox process but via a direct visible-light photolysis 
of the N-Cl bond. However, long reaction times and heat 
were necessary (24 h at 55 °C) to obtain the product 4a in 
80% yield (Table 1, entry 3).  
The limited scope with these conditions led us to explore 
the addition of  a photocatalyst/sensitizer in order to speed 
up the reaction. The use of Ir(dF(CF3)ppy)2(bpy)PF6 
(dF(CF3)ppy = 2-(2,4-difluorophenyl)-5-(trifluoromethyl) 
pyridine; bpy = 2,2′-bipyridine) reduced the reaction time 
to 1 h at 35 °C
15
 and gave the desired product in 70% yield 
(versus only 12% conversion without the catalyst at 55 °C 
– Table 1, entries 4 and 5). More dilute conditions in the 
visible-light-mediated step from 0.2 M to 0.05 M led to an 
increase of the yield to 91% (Table 1, entry 6). A transition 
metal based photocatalyst screen showed that 
Ir(dF(CF3)ppy)2(bpy)PF6 was the preferred catalyst and 
could be used with a low loading of 0.5 mol% (Table 1, 
entries 6-8). In order to study a cheaper and transition 
metal-free process, a survey of organic photocatalysts was 
then attempted (Table 1, entries 9-16): CAT-4 (9-mesityl-
10-phenylacridinium tetrafluoroborate) was found to give 
the best results, with a yield on the same range as the 
iridium catalyst (86% versus 91%). Both of these catalysts 
were chosen to explore the scope of the reaction.  
We began by exploring the scope of the visible-light-
mediated annulation using the iridium catalyst by changing 
the alkene partner 3 (Scheme 4 (A)). A mixture of two 
diastereoisomers was observed in the majority of the 
examples. Monosubstituted olefins led to pyrrolidines 4 in 
good yield (4a-4e), even in the presence of a more complex 
alkene bearing the estrone core (4f). Increasing of the 
hindrance on the alkene with 2,4,6-trimethylstyrene caused 
a decrease in yield (37%) with a corresponding rise in 
diastereoselectivity of up to 90:10. Gem-disubstituted 
olefins were suitable partners (4g-4i), even giving access to 
spiro-pyrrolidines (4j). The use of Z or E 1,2-disubstituted 
alkenes had no impact on the selectivity and gave a similar 
mixture of diastereoisomers (4k), demonstrating that the 
alkene geometry was lost during the course of the reaction. 
The major diastereoisomer was found to have a trans-trans 
configuration, as confirmed by X-ray structural analysis of 
4l (Scheme 5).
16
 Internal 1,2-disubstituted alkenes were 
also tolerated: pyrrolidine 4p derived from indane was 
prepared with 71% yield. The low yield of 37% observed in 
the case of 4q was due to a hydrogen-abstraction side 
reaction: this process can sometimes be problematic with 
nitrogen-centered radicals when the olefin partner is a good 
hydrogen donor for radical species.
5a
  
 Scheme 4. Preparation of pyrrolidines: olefin and amine scope
a
 
 
 aConditions: 1) 1 (0.2 mmol), 1,3-dichoro-5,5′-dimethylhydantoin (0.3 mmol), CH2Cl2 (0.2 M), 2 h, rt. 2) 3 (0.4 mmol), photocatalyst 
(0.5 mol%), CH2Cl2 (0.05 M in total), blue LEDs (450 nm, 14.4 W), 1 h, 35 °C. The yield corresponding to the use of 
Ir(dF(CF3)ppy)2(bpy)PF6 is indicated in bold, the one using the CAT-4 is following in italics. The diastereoselectivity ratio is given in 
parenthesis with the major diastereoisomer shown. bThe intermediate 2 was isolated by purification before using it in the photolysis step. 
The indicated yield corresponds to the overall of the 2 steps. c10 equiv. of the olefin was used. 
Internal and external aliphatic alkenes also reacted to 
form the corresponding pyrrolidines in moderate yields 
although they required a large excess of the olefin (4s-4u).  
Finally, the reaction showed good functional group 
tolerance, with electron withdrawing and donating groups 
on the aromatic ring being tolerated. A ketone (4f), a free 
alcohol (4o), heteroaromatics (4n-4r) and a second alkene 
(4d) in the molecule were tolerated as well as addition to 
enol ethers (4u). 
Next, a variety of amines 1 were examined (Scheme 4 
(B)). As the N-chlorination step was performed under 
acidic conditions, protecting groups such as acetyl, formyl 
and Boc were unsuitable for the reaction. However, a wide 
range of aromatic and heteroaromatic sulfonamides were 
found to react smoothly with styrene, leading to 
pyrrolidines in excellent yields (4v-4z), giving the 
possibility of varying the nitrogen substituent. The fact that 
the nosyl group is tolerated also offers the possibility of 
deprotection and further elaboration on the nitrogen atom 
(4w).  
Aryl-substituted alkyne amines were also efficient 
partners for the visible-light-mediated annulation reaction. 
If the free alkyne only performed the first addition to the 
styrene without the cyclization to form the pyrrolidine core, 
the phenyl-substituted alkyne amine reacted smoothly to 
lead to pyrrolidines bearing an exocyclic double bond as a 
Z/E mixture (4aa-4ac). In the case of the addition to the α-
methylstyrene, only the Z product 4ab was observed, as 
confirmed by X-ray structural analysis (Scheme 5).
17 
This 
result suggests that in the case of the Z/E mixtures observed 
for 4aa and 4ac, the major product would have a Z 
configuration.
 
Lastly, as proof of concept, a selection of examples were 
also carried out using the organic dye CAT-4. Pleasingly, 
the majority of these worked in comparable yields to the 
iridium reactions, demonstrating the possibility of having a 
cheaper and transition metal free process (Scheme 4). The 
  
visible-light-mediated annulation was then carried out on 
3.5 mmol scale, using the organic dye CAT-4, with 1.07 g 
(88%) of pyrrolidine 4a prepared (Scheme 6). 
Scheme 5. X-rays analyses of compounds 4l (major dia-
stereoisomer) and 4ab
a
 
 
aDisplacement ellipsoids are shown at 50% probability for 
compounds 4l and 4ab. 
Scheme 6. Larger scale preparation of pyrrolidine 4a 
 
To gain insight into the course of the reaction, a control 
experiment was performed in the presence of the radical 
scavenger 2,2,6,6-tetramethylpiperidine-1-oxyl (TEMPO): 
wherby the reaction was completey inhibited and no 
product was observed. From a mechanistic perspective, it 
was determined that the intramolecular radical cyclization 
occurred via a 5-exo-trig mode as no 6-membered ring was 
observed by 
1
H NMR analysis during the investigation. 
Scheme 7 shows a plausible mechanism for the annulation. 
While a photoredox initiated process cannot be completely 
ruled out,
18
 the method of initiation of the radical seems to 
be more likely photosensitization, a physical process of 
energy transfer,
19 
as the reaction was found to proceed 
without a catalyst. Indeed, if light itself can slowly excite 
the intermediate 2 (in 24 h at 55 °C), the presence of a 
catalyst promotes a faster and milder activation of 2 (35 °C, 
1 h). A plausible mechanism would be that the 
photocatalyst CAT absorbs a photon to generate a long 
lived, excited triplet state CAT*,
6,20
 which would then 
transfer its energy to the intermediate 2 while the catalyst 
returns to its ground state. It is envisaged that the excited 
molecule 2* undergoes a homolytic cleavage of the 
nitrogen-chloride bond to form a nitrogen-centered radical 
which would then initiate the radical reaction. The 
nitrogen-centered radical would first attack in an 
intermolecular fashion the alkene 3 to form a carbon-
centered radical which then would induce the formation of 
the pyrrolidine core via an intramolecular reaction with the 
allyl group. The remaining radical would finally trap the 
chlorine radical to lead to the product 4. A typical 
propagation step would also result in C-Cl bond formation. 
Scheme 7. Proposed mechanism 
 
Analyses by 
1
H NMR and NOESY experiments of 
pyrrolidine 4l (where both diastereoisomers were isolated 
pure) and 4r (mixture of both diastereoisomers), as well as 
X-ray structural analysis of the major diastereoisomer of 4l 
allowed us to define the stereochemistry of the different 
stereogenic centers (Scheme 8). The reaction pathway 
seems to favor the thermodynamic product, providing a 
trans-trans configuration. Control of the relative 
stereochemistry at the C2 and C3 positions was found to be 
high, with only one configuration observed: the use of Z or 
E 1,2-disubstituted alkenes gave an identical mixture of 
diastereoisomers, indicating that the alkene geometry was 
lost during the course of the reaction.
7,21
 The analyses 
indicate that the major diastereoisomer has a trans 
configuration between the C2/C3 group to minimize steric 
hindrance. The only exception is when using an internal 
alkene where the C2/C3 configuration is forced to remain 
cis by ring strain. The selectivity between the carbons C3 
and C4 proceeds with lower diastereoselectivity during the 
radical cyclization (dr from 53:47 to 90:10), still in favor of 
the thermodynamic product, providing a trans 
configuration between the C3 and C4 groups (Scheme 8).
22
 
Scheme 8. Regioselectivity observed by 
1
H,  NOESY NMR 
and X-ray structural analyses 
 
  
Finally, we studied further manipulation of the 
cycloadducts to demonstrate the potential for further 
elaboration (Scheme 9). Pyrrole 5 was prepared via an HCl 
elimination/oxidation process from 4a. The chlorine 
functionality could be exchanged by morpholine or an 
azide group through nucleophilic substitution (6, 7). The 
small nucleophile azide reacted with 4a with no 
discrimination between the two diastereoisomers. On the 
other hand, the product 7 was isolated with 56% yield as 
one diastereoisomer: only the major diastereoisomer of 4a 
was found to react with morpholine, due to the more 
hindered nature of the nucleophile.
23 
Previously unknown 
fused pyrrole 9 could also be prepared by the two steps 
HCl elimination/oxidation procedure. Pyrrolidine 4ab 
could be used in a palladium-catalyzed Suzuki-Miyaura 
coupling to form tetra-substituted alkene 10. Finally, 
hydrogenation of 4ab was seen to lead to compound 11 in 
72% yield with good diastereoselectivity (dr = 86:14), with 
hydrogenation preferentially occurring on the least 
hindered face.  
Scheme 9. Synthetic transformations of chloromethylated 
pyrrolidines 4 
 
CONCLUSIONS 
In conclusion, we have reported a simple, mild and 
regioselective approach to access chloromethylated 
pyrrolidine derivatives in good to excellent yields with 
moderate to good diastereoselectivity through a visible-
light-mediated annulation of N-sulfonylallylamines with 
alkenes. This method allows the formation of three new 
bonds starting from simple and readily available starting 
materials, giving access to 29 different pyrrolidine 
products, of which 24 were previously unknown. This 
method demonstrates a wide range of functional group 
compatibility and is complementary to the classical [3+2] 
cycloaddition, bringing more diversity to the substitution 
pattern of pyrrolidines by enabling the use of electron-
neutral and electron-rich olefins.  
EXPERIMENTAL SECTION 
General Experimental Methods. Unless otherwise stated, 
reagents were obtained from commercial sources and used 
without further purification. Alkenes 3 were commercialy 
available except for 3f, 3j, 3l, 3n and 3s (numbering for the 
starting materials 3 can be found in SI). Solvents were freshly 
distilled over calcium hydride and lithium aluminium hydride 
(tetrahydrofuran and diethyl ether) or calcium hydride 
(dichloromethane, methanol, n-hexanes, toluene, and ethyl 
acetate). Analytical thin layer chromatography (TLC) was 
performed on pre-coated silica gel glass plates (Merck 60 F254), 
visualised using ultraviolet light (254 nm) or an alkaline solution 
of potassium permanganate. Flash column chromatography (FCC) 
was performed whether using high-purity grade silica gel Merck 
with 60-120 mesh particle size under air pressure or using 
Florisil® with 100-200 mesh particle under air pressure (as 
Florisil® was giving better yields than silica gel for the 
pyrrolidine purification- increase of the yield up to 5-10%). All 
solvents used for chromatographic purification were distilled prior 
to use. 1H-NMR spectra were recorded on a DRX-600 
spectrometer at 600 MHz and are reported as follows: chemical 
shift δ in ppm (multiplicity, coupling constants J in Hz, number of 
protons). The multiplicity and shape of the 1H signals are 
designated by the following abbreviations: s = singlet, 
d = doublet, t = triplet, q = quartet, m = multiplet, br. = broad, or 
combinations of thereof. All chemical shifts δ are reported to the 
nearest 0.01 (1H) / 0.1(13C) ppm, relative to the residual protic 
solvent as the internal reference (CDCl3 = 7.26 (
1H) / 77.16 (13C) 
ppm). 19F-NMR spectra were recorded on a Bruker DPX-400 
spectrometer at 376 MHz with 1H decoupling. All chemical shifts 
δ are reported to the nearest 0.1 ppm with CFCl3 as the external 
standard (CFCl3 = 0.0 ppm). Spectra were assigned using 
1H-
COSY, DEPT-135, HSQC and HMBC where appropriate to 
facilitate structural determination. Assignement was made for 1H 
and 13C NMR of pyrrolidines. Infrared spectra were recorded neat 
as thin films on a Perkin-Elmer Spectrum One FTIR 
spectrometer. Absorbances were recored in the range 4000-650 
cm-1. High resolution mass spectrometry (HRMS) was performed 
using whether a Waters Micromass LCT Premier™ spectrometer 
using time of flight mass detection and positive electrospray 
ionization method (+ESI), a Waters Vion IMS Qtof spectrometer 
using positive electrospray ionization method (+ESI) or a Waters 
Xevo G25 Qtof spectrometer using Atmospheric Solids Analysis 
Probe ionization method (ASAP+). All reported values are within 
5 ppm of the calculated value. Melting points were recorded on a 
Stuart Scientific SMP3 melting point apparatus. The lamps 
utilized for the visible-light-mediated reaction were blue LEDs 
(450 nm, 14.4 W). 
Preparation of catalysts. Ir(dF(CF3)ppy)2(bpy)PF6 was kindly 
furnished by Merck Rahway USA. fac-Ir(ppy)3, Ru(bpy)3(PF6)2, 
eosin Y, fluorescein, TPT (2,4,6-triphenylpyrylium 
tetrafluoroborate), CAT-1 (9-mesityl-10-methylacridinium 
tetrafluoroborate), CAT-2 (9-mesityl-10-methylacridinium 
perchlorate), CAT-3 (9-mesityl-2,7-dimethyl-10-
phenylacridinium tetrafluoroborate) and CAT-4 (9-mesityl-10-
phenylacridinium tetrafluoroborate) were commercially available. 
4CzlPN was prepared according to published literature 
  
procedures. Spectral data were in agreement with literature 
values.24 
General Procedure A: Preparation of sulfonylamines 1a-1f.25 
In an oven-dried flask under argon was placed the amine 
(1.1 equiv.) in CH2Cl2 (0.25 M). The reaction mixture was cooled 
to 0 °C and triethylamine (1.1 equiv.) was added. The 
corresponding sulfonylchloride (1.0 equiv.) was then added in 
small portions and the reaction mixture was stirred at 0 °C for 1 h, 
then 18 h at room temperature. The crude was added to a satured 
solution of NaHCO3 and the aqueous layer was extracted with 
CH2Cl2 (3x). The organic layer was washed with brine, dried over 
MgSO4, filtered and concentrated in vacuo to yield the desired 
product. 
N-allyl-4-methylbenzenesulfonamide (1a). According to general 
procedure A and starting from 1.95 g of tosylchloride (10 mmol), 
isolated as a white solid (1.96 g, 9.3 mmol, 93%). Spectral data 
were in agreement with literature values.25  
N-allyl-4-methoxybenzenesulfonamide (1b). According to 
general procedure A and starting from 1.88 g of 4-
methoxybenzenesulfonyl chloride (9.1 mmol), isolated as an off-
white solid (2.10 g, 9.1 mmol, quant.). Spectral data were in 
agreement with literature values.26  
N-allyl-4-nitrobenzenesulfonamide (1c). According to general 
procedure A and starting from 1.99 g of 4-nitrobenzenesulfonyl 
chloride (9.0 mmol), isolated as an off-white solid (1.48 g, 
6.1 mmol, 68%). Spectral data were in agreement with literature 
values.26  
N-allyl-5-(5-(trifluoromethyl)isoxazol-3-yl)thiophene-2-
sulfona-mide (1d). According to general procedure A and 
starting from 635 mg of 5-(5-(trifluoromethyl)isoxazol-3-
yl)thiophene-2-sulfonyl chloride (2.0 mmol), isolated as a white 
solid (500 mg, 1.48 mmol, 74%). Rf 0.18 (30% EtOAc/hexane); 
1H NMR (CDCl3) δ 7.63 (d, J = 3.9 Hz), 7.47 (d, J = 3.9 Hz, 1H), 
6.98 (d, J = 1.0 Hz, 1H), 5.79 (ddt, J = 17.1, 10.2, 5.6 Hz, 1H), 
5.25 (dq, J = 17.1, 1.5 Hz, 1H), 5.18 (dq, J = 10.2, 1.5 Hz, 1H), 
4.67 (t, J = 6.2 Hz, 1H), 3.76 (tt, J = 6.2, 1.5 Hz, 2H); 13C NMR 
(CDCl3) δ 156.7, 144.1, 134.5, 132.3, 132.2, 128.1, 118.4, 103.4, 
46.0; 19F NMR (CDCl3) δ -65.1; FTIR (νmax cm
-1) 3270 (NH), 
1552 (C=C), 1322 (sulfone), 1154 (sulfone); HRMS (ESI+) 
calculated for C11H10O3N2S2F3 [M+H]
+ 339.0085, found 
339.0076; M.p.: 124-127 °C. 
N-allyl-1-methyl-1H-imidazole-4-sulfonamide (1e). According 
to general procedure A and starting from 361 mg of 1-methyl-1H-
imidazole-4-sulfonyl chloride (2.0 mmol), isolated as a white 
solid (146 mg, 0.73 mmol, 36%). Rf 0.22 (10% MeOH/CH2Cl2); 
1H NMR (CDCl3) δ 7.51 (d, J = 1.4 Hz, 1H), 7.47 (d, J = 1.4 Hz, 
1H), 5.84-5.77 (m, 1H), 5.23 (dd, J = 17.1, 1.6 Hz, 1H), 5.15 (br 
s, 1H), 5.12 (dd, J = 10.2, 1.6 Hz, 1H), 3.76 (s, 3H), 3.65 (t, 
J = 6.0 Hz, 2H); 13C NMR (CDCl3) δ 140.2, 139.0, 133.3, 124.0, 
117.4, 45.9, 34.0; FTIR (νmax cm
-1) 3168 (NH), 1534 (C=C), 2857 
(sp3 C-H), 1358 (sulfone), 1158 (sulfone); HRMS (ESI+) 
calculated for C7H12O2N3S [M+H]
+ 202.0650, found 202.0654; 
M.p.: 136-138 °C. 
N-allyl-3,5-dimethylisoxazole-4-sulfonamide (1f). According to 
general procedure A and starting from 391 mg of 3,5-
dimethylisoxazole-4-sulfonyl chloride (2.0 mmol), isolated as a 
colorless oil (273 mg, 1.26 mmol, 63%). Rf 0.21 (50% 
EtOAc/hexane); 1H NMR (CDCl3) δ 5.75 (ddt, J = 17.1, 10.2, 5.9 
Hz, 1H), 5.21 (dd, J = 17.1, 1.2 Hz, 1H), 5.16 (dd, J = 10.2, 
1.2 Hz, 1H), 4.75 (t, J = 6.3 Hz, 1H), 3.63 (tt, J = 6.3, 1.2 Hz, 
2H), 2.63 (s, 3H), 2.41 (s, 3H); 13C NMR (CDCl3) δ 173.1, 157.5, 
132.6, 118.3, 118.2, 116.2, 45.3, 12.7, 10.8; FTIR (νmax cm
-1) 
3294 (NH), 2929 ((sp3 C-H), 1596 (C=C), 1326 (sulfone), 1175 
(sulfone); HRMS (ESI+) calculated for C8H13O3N2S [M+H]
+ 
217.0647, found 217.0656. 
4-methyl-N-(3-phenylprop-2-yn-1-yl)benzenesulfonamide 
(1g). To a solution of 4-methyl-N-(prop-2-yn-1-
yl)benzenesulfonamide (628 mg, 3 mmol, 1.0 equiv.), 
PdCl2(PPh3)2 (42 mg, 0.06 mmol, 0.02 equiv.) and CuI (22 mg, 
0.12 mmol, 0.04 equiv.) in THF (0.2 M) were added phenyl iodide 
(0.4 mL, 3.6 mmol, 1.2 equiv.) and Et3N (1.25 mL, 9 mmol, 
3 equiv.) successively under an argon atmosphere. The resulting 
mixture was stirred at room temperature for 18 h. The crude was 
filtered through a small pad of celite and the filtrate was 
concentrated under reduced pressure. The crude was purified by 
silica flash column chromatography (85/15 to 7/3 hexane/EtOAc) 
to yield the desired amine 1g as an off-white solid (613 mg, 
2.15 mmol, 72%).27 Spectral data were in agreement with 
literature values.28  
N-allyl-N-chloro-4-methylbenzenesulfonamide (2a). In an 
oven-dried flask under argon were placed the amine 1a (500 mg, 
2.37 mmol, 1 equiv.) and 1,3-dichloro-5,5′-dimethylhydantoin 
(699 mg, 3.55 mmol, 1.5 equiv.) in CH2Cl2 (12 mL, 0.2 M). The 
reaction mixture was stirred at room temperature for 2 h. The 
crude was concentrated in vacuo and then purified by silica flash 
column chromatography to afford the desired product 2a as a 
clear yellow oil (580 mg, 2.36 mmol, 99%). Rf 0.55 (30% 
EtOAc/hexane); 1H NMR (CDCl3) δ 7.83 (d, J = 8.0 Hz, 2H), 
7.40 (d, J = 8.0 Hz, 2H), 5.86-5.77 (m, 1H), 5.33-5.26 (m, 2H), 
3.86 (dd, J = 6.5, 1.3 Hz, 2H), 2.48 (s, 3H); 13C NMR (CDCl3) δ 
145.5, 130.6, 129.9, 129.7, 129.6, 121.1, 59.3, 21.7; FTIR (νmax 
cm-1) 2977 (sp3 C-H), 2911 (sp3 C-H), 1596 (C=C), 1356 
(sulfone), 1157 (sulfone); HRMS (ESI+) calculated for 
C10H13O2NSCl [M+H]
+ 246.0350, found 246.0344.  
(8R,9S,13S,14S)-13-methyl-3-vinyl-6,7,8,9,11,12,13,14,15,16-
decahydro-17H-cyclopenta[a]phenanthren-17-one (3f). 
Prepared according to published literature procedure. Spectral 
data were in agreement with literature values.29  
General Procedure B: Preparation of alkenes 3j, 3l, 3n and 3s. 
Following a typical Wittig reaction procedure, the alkyl 
phosphonium bromide (2.0 equiv.) was suspended in THF (0.2 M) 
under an argon atmosphere and the reaction mixture was cooled 
to 0 °C. tBuOK (2.0 equiv.) was added in one portion and the 
mixture was sitrred for 15 min. Then, a solution of the 
aldehyde/ketone (1.0 equiv.) in THF (1 mL/mmol) was added 
dropwise. After 1 h, the reaction mixture was warmed to room 
temperature and stirred for 18 h. Satured NH4Cl was then added, 
the two phases separated and the aqueous phase was extracted 
with diethyl ether (x3). The organic phase was dried over MgSO4, 
filtered and solvent was removed in vacuo. The crude was 
purified by silica flash column chromatography (95/5 
hexane/EtOAc) to yield the desired alkene precursor. 
1-methylene-1,2,3,4-tetrahydronaphthalene (3j). According to 
general procedure B and starting from 0.67 mL of 3,4-
dihydronaphthalen-1(2H)-one (5.0 mmol), isolated as clear 
yellow oil (649 mg, 4.5 mmol, 90%). Spectral data were in 
agreement with literature values.30  
1-methoxy-4-(prop-1-en-1-yl)benzene (3l). According to general 
procedure B and starting from 817 mg of 2-methoxybenzaldehyde 
(6.0 mmol), isolated as a clear yellow oil (646 mg, 4.4 mmol, 
73%) of a Z/E 1/1 non separable mixture. Spectral data were in 
agreement with literature values.31  
2-phenyl-5-(prop-1-en-1-yl)thiophene (3n). According to 
general procedure B and starting from 377 mf of 5-
phenylthiophene-2-carbaldehyde (2.0 mmol), isolated as an 
orange solid (346 mg, 1.7 mmol, 87%) of a Z/E 75/25 non 
separable mixture. Rf 0.68 (20% EtOAc/hexane); 
1H NMR 
(CDCl3) δ alkene Z 7.64-7.60 (m, 2H), 7.40-7.25 (m, 3H), 7.24 (d, 
J = 3.7 Hz, 1H), 6.96 (d, J = 3.7 Hz, 1H), 6.58-6.53 (m, 1H), 5.72 
(dq, J = 11.4, 7.3 Hz, 1H), 2.04 (dd, J = 7.3, 1.8 Hz, 3H) alkene E 
7.60-7.56 (m, 2H), 7.40-7.25 (m, 3H), 7.15 (d, J = 3.7 Hz, 1H), 
6.82 (d, J = 3.7 Hz, 1H), 6.53-6.47 (m, 1H), 6.10 (dq, J = 15.6, 
6.8 Hz, 1H), 1.88 (dd, J = 6.8, 1.8 Hz, 3H); 13C NMR (CDCl3) δ 
alkene E/Z 143.7, 142.6, 141.6, 140.4, 134.4, 134.3, 128.9, 128.8, 
128.1, 127.3, 127.2, 125.9, 125.6, 125.5, 125.1, 124.9, 124.4, 
123.2, 123.1, 122.7, 18.4, 15.2; FTIR (νmax cm
-1) 2906 (sp3 C-H), 
  
2846 (sp3 C-H), 1597 (C=C); HRMS (ASAP+) calculated for 
C13H12S [M]
+ 200.0660, found 200.0653; M.p.: 42-44 °C (lit. 
43 °C).32 
1-(tert-butyl)-4-methylenecyclohexane (3s). According to 
general procedure B and starting from 0.93 g of 4-
tertbutylcyclohexanone (6.0 mmol), isolated as a colorless oil 
(630 mg, 4.1 mmol, 69%). Spectral data were in agreement with 
literature values.33  
General Procedure C: Preparation of pyrrolidines 4a-4ac. 
Conditions C1: A 10 mL microwave vial was charged with the 
amine 1 (0.2 mmol, 1.0 equiv.), 1,3-dichloro-5,5′-
dimethylhydantoin (0.3 mmol, 1.5 equiv.) and CH2Cl2 (1 mL, 
0.2 M). The tube was flushed with argon and the reaction mixture 
was stirred for 2 h at room temperature. Then, the corresponding 
alkene 3 (0.4 mmol, 2 equiv.), Ir(dF(CF3)ppy)2(bpy)PF6 
(0.001 mol, 0.5 mol%) and CH2Cl2 (3 mL, 0.05 M in total) were 
successively added and the reaction mixture was stirred at 35 °C 
under blue LEDs irradation (450 nm, 14.4 W) for 1 h. The crude 
was concentrated in vacuo and purified by Florisil® flash column 
chromatography to yield the desired pyrrolidine 4 as a mixture of 
two diastereoisomers. Conditions C2: Same conditions using 
CAT-4 (0.001 mol, 0.5 mol%) as the photosensitizer.  
 
3-(chloromethyl)-4-phenyl-1-tosylpyrrolidine (4a). According 
to general procedure C1, isolated as a clear yellow oil (64 mg, 
0.183 mmol, 91%) of a mixture of non separable diastereoisomers 
(dr = 70:30). With general procedure C2 (60 mg, 0.171 mmol, 
86%). A larger scale reaction was performed using conditions C1, 
starting with 3.5 mmol of amine 1a, to prepare the product 4a 
(1.07 g, 3.07 mmol, 88%). Rf 0.41 (30% EtOAc/hexane); 
1H 
NMR (CDCl3) δ major diastereoisomer 7.77 (d, J = 7.9 Hz, 2H), 
7.41-7.37 (m, 2H), 7.32-7.24 (m, 3H), 7.11 (d, J = 7.4 Hz, 2H), 
3.77-3.66 (m, 2H, H1, H4), 3.46 (dd, J = 11.3, 4.0 Hz, 1H, H5), 
3.37-3.27 (m, 3H, H1, H4, H5), 3.06-3.00 (m, 1H, H2), 2.56-2.50 
(m, 1H, H3), 2.48 (s, 3H); minor diastereoisomer 7.81 (d, 
J = 7.9 Hz, 2H), 7.41-7.37 (m, 2H), 7.32-7.24 (m, 3H), 7.06 (d, 
J = 7.4 Hz, 2H), 3.77-3.66 (m, 1H, H1’), 3.64-3.60 (m, 2H, H1’, 
H4’), 3.52-3.48 (m, 1H, H2’), 3.37-3.27 (m, 1H, H4’), 3.06-3.00 
(m, 1H, H5’), 2.82 (dd, J = 11.3, 9.2 Hz, 1H, H5’), 2.66-2.61 (m, 
1H, H3’), 2.48 (s, 3H); 13C NMR (CDCl3) δ major 
diastereoisomer 143.8, 138.4, 133.5, 129.8, 129.0, 127.6, 127.4, 
127.3, 54.6 (C1), 51.3 (C4), 48.0 (C3), 47.3 (C2), 44.2 (C5), 21.6; 
minor diastereoisomer 143.8, 137.5, 133.8, 129.9, 128.8, 127.8, 
127.5, 127.3, 52.5 (C1’), 50.3 (C4’), 45.8 (C2’), 45.6 (C3’), 43.1 
(C5’), 21.6; FTIR (νmax cm
-1) 2959 (sp3 C-H), 2878 (sp3 C-H), 
1346 (sulfone), 1159 (sulfone); HRMS (ESI+) calculated for 
C18H20ClNO2S [M+H]
+ 350.0976, found 350.0977. 
 
3-(chloromethyl)-4-(o-tolyl)-1-tosylpyrrolidine (4b). According 
to general procedure C1, isolated as a colorless oil (62.8 mg, 
0.173 mmol, 86%) of a mixture of non separable diastereoisomers 
(dr = 73:27). Rf 0.42 (30% EtOAc/hexane); 
1H NMR (CDCl3) δ 
major diastereoisomer 7.77 (d, J = 8.2 Hz, 2H), 7.40-7.35 (m, 
2H), 7.16-7.11 (m, 3H), 7.03-6.99 (m, 1H), 3.74 (dd, J = 10.0, 
7.7 Hz, 1H, H1), 3.72-3.63 (m, 1H, H4), 3.44 (dd, J = 11.3, 4.2 
Hz, 1H, H5), 3.34 (dd, J = 10.5, 8.1 Hz, 1H, H4), 3.30-3.25 (m, 
2H, H2, H5), 3.20 (dd, J = 10.0, 8.9 Hz, 1H, H1), 2.64-2.56 (m, 
1H, H3), 2.47 (s, 3H), 2.26 (s, 3H); minor diastereoisomer 7.80 
(d, J = 8.2 Hz, 2H), 7.40-7.35 (m, 2H), 7.16-7.11 (m, 2H), 7.10-
7.06 (m, 1H), 6.93 (d, J = 7.7 Hz, 1H), 3.72-3.63 (m, 3H, H1’, H2’, 
H4’), 3.59-3.56 (m, 1H, H1’), 3.48 (dd, J = 10.8, 4.9 Hz, 1H, H4’), 
2.99-2.96 (m, 1H, H5’), 2.77-2.70 (m, 2H, H3’, H5’), 2.47 (s, 3H), 
2.27 (s, 3H); 13C NMR (CDCl3) δ major diastereoisomer 143.8, 
136.6, 136.5, 133.6, 130.8, 129.8, 127.6, 127.2, 126.7, 125.5, 54.3 
(C1), 50.1 (C4), 47.4 (C3), 44.3 (C2), 42.5 (C5), 21.6, 19.7; minor 
diastereoisomer 143.8, 136.2, 135.2, 133.4, 130.9, 129.8, 127.6, 
127.3, 126.4, 126.3, 51.9, 51.2, 43.8, 43.7, 42.1, 21.6, 19.9; FTIR 
(νmax cm
-1) 2957 (sp3 C-H), 2861 (sp3 C-H), 1343 (sulfone), 1159 
(sulfone); HRMS (ESI+) calculated for C19H23ClNO2S [M+H]
+ 
364.1133, found 364.1126. 
 
3-(chloromethyl)-4-mesityl-1-tosylpyrrolidine (4c). According 
to general procedure C1, isolated as a colorless oil (28.7 mg, 
0.073 mmol, 37%) of a mixture of non separable diastereoisomers 
(dr = 90:10). Rf 0.48 (30% EtOAc/hexane); 
1H NMR (CDCl3) δ 
major diastereoisomer 7.75 (d, J = 8.0 Hz, 2H), 7.37 (d, 
J = 8.0 Hz, 2H), 6.80 (s, 2H), 3.79 (dd, J = 10.0, 7.5 Hz, 1H, H4), 
3.51-3.44 (m, 4H, 2H1, H2, H5), 3.32 (dd, J = 11.2, 7.1 Hz, 1H, 
H5), 3.14 (dd, J = 11.2, 7.5 Hz, 1H, H4), 3.01-2.94 (m, 1H, H3), 
2.47 (s, 3H), 2.22 (s, 9H); minor diastereoisomer when seen 7.84 
(d, J = 8.0 Hz, 2H), 7.39-7.34 (m, 2H), 6.89 (s, 2H), 2.47 (s, 3H), 
2.20 (s, 9H); 13C NMR (CDCl3) δ major diastereoisomer 143.7, 
136.7, 132.8, 131.2, 129.7, 127.9, 127.8, 51.8 (C1 or C4), 51.7 (C1 
or C4), 45.2 (C2 or C3), 45.1 (C2 or C3), 41.9 (C5), 21.6, 20.6; 
minor diastereoisomer signals for carbons were not observed; 
FTIR (νmax cm
-1) 2926 (sp3 C-H), 2856 (sp3 C-H), 1346 (sulfone), 
1161 (sulfone); HRMS (ESI+) calculated for C21H27ClNO2S 
[M+H]+ 392.1446, found 392.1434. 
 
3-(chloromethyl)-1-tosyl-4-(2-vinylphenyl)pyrrolidine (4d). 
According to general procedure C1, isolated as a colorless oil 
(55.1 mg, 0.147 mmol, 73%) of a mixture of non separable 
diastereoisomers (dr = 72:28). Rf 0.45 (30% EtOAc/hexane); 
1H NMR (CDCl3) δ major diastereoisomer 7.78 (d, J = 7.6 Hz, 
2H), 7.41-7.36 (m, 2H), 7.35-7.20 (m, 2H), 7.14-7.00 (m, 2H), 
6.71-6.56 (m, 1H, H6), 5.75-5.68 (m, 1H, H7a), 5.29-5.24 (m, 1H, 
H7b), 3.76-3.68 (m, 2H, H1, H4), 3.52-3.45 (m, 1H, H5), 3.37-3.27 
(m, 3H, H1, H4, H5), 3.06-2.98 (m, 1H, H2), 2.56-2.50 (m, 1H, 
H3), 2.48 (s, 3H); minor diastereoisomer 7.81 (d, J = 7.6 Hz, 2H), 
7.41-7.36 (m, 2H), 7.35-7.20 (m, 2H), 7.14-7.00 (m, 2H), 6.71-
6.56 (m, 1H, H6’), 5.75-5.68 (m, 1H, H7a’), 5.29-5.24 (m, 1H, 
H7b’), 3.76-3.68 (m, 1H, H1’), 3.65-3.60 (m, 2H, H1’, H4’), 3.52-
3.45 (m, 1H, H2’), 3.37-3.27 (m, 1H, H4’), 3.06-2.98 (m, 1H, H5’), 
2.86-2.81 (m, 1H, H5’), 2.67-2.59 (m, 1H, H3’), 2.48 (s, 3H); 13C 
NMR (CDCl3) δ major diastereoisomer 143.8, 138.8, 138.3, 
136.3 (C6), 133.6, 129.8, 129.2, 127.6, 126.7, 125.4, 125.3, 114.6 
(C7), 54.5 (C1), 51.3 (C4), 47.9 (C3), 47.3 (C2), 44.1 (C5), 21.6; 
minor diastereoisomer 143.7, 138.1, 137.8, 136.4 (C6’), 133.9, 
129.9, 129.0, 127.5, 125.8, 125.1, 124.6, 114.2 (C7’), 52.5 (C1’), 
50.3 (C4’), 45.7 (C2’ or C3’), 45.6 (C2’ or C3’), 43.0 (C5’), 21.6; 
FTIR (νmax cm
-1) 2957 (sp3 C-H), 2871 (sp3 C-H), 1596 (C=C), 
1340 (sulfone), 1154 (sulfone); HRMS (ESI+) calculated for 
C20H23ClNO2S [M+H]
+ 376.1133, found 376.1117. 
  
 
3-(chloromethyl)-4-(4-nitrophenyl)-1-tosylpyrrolidine (4e). 
According to general procedure C1, isolated as a colorless oil 
(62.1 mg, 0.157 mmol, 79%) of a mixture of non separable 
diastereoisomers (dr = 70:30). Rf 0.27 (30% EtOAc/hexane); 
1H NMR (CDCl3) δ major diastereoisomer 8.17 (d, J = 8.8 Hz, 
2H), 7.76 (d, J = 8.2 Hz, 2H), 7.41-7.38 (m, 2H), 7.32-7.30 (m, 
2H), 3.72 (dd, J = 10.3, 7.9 Hz, 2H, H1, H4), 3.44 (dd, J = 11.5, 
4.7 Hz, 1H, H5), 3.38 (dd, J = 10.3, 8.3 Hz, 1H, H1), 3.32 (dd, 
J = 11.5, 6.6 Hz, 1H, H5), 3.29-3.22 (m, 2H, H2, H4), 2.60-2.54 
(m, 1H, H3), 2.48 (s, 3H); minor diastereoisomer 8.13 (d, 
J = 8.8 Hz, 2H), 7.79 (d, J = 8.2 Hz, 2H), 7.41-7.38 (m, 2H), 
7.32-7.30 (m, 2H), 3.68-3.65 (m, 1H, H1’), 3.63-3.60 (m, 2H, H2’, 
H4’), 3.29-3.22 (m, 1H, H1’), 3.21-3.15 (m, 1H, H4’), 2.95 (dd, 
J = 11.2, 7.8 Hz, 1H, H5’), 2.88 (dd, J = 11.2, 7.3 Hz, 1H, H5’), 
2.73-2.69 (m, 1H, H3’), 2.49 (s, 3H); 13C NMR (CDCl3) δ major 
diastereoisomer 146.7, 144.1, 133.1, 129.9, 128.9, 128.3, 127.7, 
124.2, 54.0 (C1), 50.9 (C4), 48.1 (C3), 46.9 (C2), 43.8 (C5), 21.6; 
minor diastereoisomer 147.4, 145.3, 133.1, 130.0, 128.9, 128.3, 
127.5, 123.9, 52.7 (C1’), 49.7 (C4’), 45.6 (C3’), 45.4 (C2’), 42.2 
(C5’), 21.6;  FTIR (νmax cm
-1) 2954 (sp3 C-H), 2925 (sp3 C-H), 
1516 (NO2), 1343 (NO2 and sulfone), 1155 (sulfone); HRMS 
(ESI+) calculated for C18H20ClN2O4S [M+H]
+ 395.0832, found 
395.0824. 
 
3-(4-(chloromethyl)-1-tosylpyrrolidin-3-yl)-13-methyl-
6,7,8,9,11,12,13,14,15,16-decahydro-17H-cyclopenta[a]phenan-
thren-17-one (4f). According to general procedure C1, isolated as 
a colorless oil (89.5 mg, 0.170 mmol, 85%) of a mixture of non 
separable diastereoisomers (dr = 76:24). Rf 0.24 (30% 
EtOAc/hexane); 1H NMR (CDCl3) δ major diastereoisomer 7.75 
(d, J = 8.2 Hz, 2H), 7.39-7.35 (m, 2H), 7.20 (d, J = 8.2 Hz, 1H), 
6.87 (d, J = 8.2 Hz, 1H), 6.83-6.79 (m, 1H), 3.72-3.68 (m, 2H, H1, 
H4), 3.46 (dd, J = 11.3, 3.9 Hz, 1H, H5), 3.35-3.23 (m, 3H, H1, H4, 
H5), 2.96 (d, J = 9.6 Hz, 1H, H2), 2.87-2.83 (m, 2H, 2H6), 2.53-
2.48 (m, 2H, H3, H10), 2.47 (s, 3H), 2.40-2.35 (m, 1H, H16), 2.29-
2.21 (m, 1H, H17), 2.17-2.10 (m, 1H, H10), 2.09-1.98 (m, 2H, H7, 
H11), 1.97-1.93 (m, 1H, H15), 1.67-1.38 (m, 5H, H7, H8, H9, H11, 
H15, H16), 0.90 (s, 3H, H14); minor diastereoisomer 7.79 (d, J = 
8.2 Hz, 2H), 7.39-7.35 (m, 2H), 7.16 (d, J = 8.2 Hz, 1H), 6.83-
6.79 (m, 1H), 6.72 (d, J = 18.3 Hz, 1H), 3.67-3.64 (m, 1H, H1’), 
3.63-3.59 (m, 1H, H4’), 3.57 (dd, J = 10.1, 4.8 Hz, 1H, H1’), 3.43-
3.40 (m, 1H, H2’), 3.35-3.23 (m, 1H, H4’), 3.08-3.03 (m, 1H, H5’), 
2.82-2.75 (m, 3H, H5’, 2H6’), 2.63-2.56 (m, 1H, H3’), 2.53-2.48 
(m, 1H, H10’), 2.47 (s, 3H), 2.40-2.35 (m, 1H, H16’), 2.29-2.21 (m, 
1H, H17’), 2.17-2.10 (m, 1H, H10’), 2.09-1.98 (m, 2H, H7’, H11’), 
1.97-1.93 (m, 1H, H15’), 1.67-1.38 (m, 6H, H7’, H8’, H9’, H11’, H15’, 
H16’), 0.90 (s, 3H, H14’); 13C NMR (CDCl3) δ major 
diastereoisomer 220.6 (C11), 143.7, 139.2, 137.2, 135.8, 136.6, 
129.8, 128.0, 127.6, 125.9, 124.8, 54.6 (C1), 51.4 (C13), 50.4 (C4), 
47.9 (C3), 46.9 (C2), 44.3 (C5 and C17), 38.0 (C11), 35.8 (C10), 31.5 
(C15), 29.4 (C6), 26.4 (C7), 25.6 (C16), 21.6, 13.8 (C14); minor 
diastereoisomer 220.6 (C11’), 143.7, 139.0, 137.0, 134.8, 133.8, 
129.9, 128.2, 127.5, 125.7, 125.3, 52.5 (C1’), 51.4 (C13’), 50.3 
(C4’), 45.6 (C3’), 46.9 (C2’),  44.3 (C5’ or C17’), 43.2 (C5’ or C17’), 
38.0 (C11’), 35.8 (C10’), 31.5 (C15’), 29.6 (C6’), 26.4 (C7’), 25.6 
(C16’), 21.6, 13.8 (C14’); FTIR (νmax cm
-1) 2924 (sp3 C-H), 2863 
(sp3 C-H), 1734 (C=O), 1338 (sulfone), 1161 (sulfone); HRMS 
(ESI+) calculated for C30H36ClNO3SNa [M+Na]
+ 548.1996, 
found 548.1991. 
 
4-(chloromethyl)-3-methyl-3-phenyl-1-tosylpyrrolidine (4g). 
According to general procedure C1, isolated as a colorless oil 
(72.9 mg, 0.2 mmol, 99%) of a mixture of non separable 
diastereoisomers (dr = 79:21). With general procedure C2 
(60.1 mg, 0.153 mmol, 83%). Rf 0.47 (30% EtOAc/hexane); 
1H NMR (CDCl3) δ major diastereoisomer 7.76 (d, J = 8.0 Hz, 
2H), 7.36 (d, J = 8.0 Hz, 2H), 7.34-7.21 (m, 5H), 3.77 (dd, 
J = 10.4, 8.0 Hz, 1H, H4), 3.49-3.43 (m, 3H, 2H1, H5), 3.32 (dd, 
J  = 10.4, 9.0 Hz, 1H, H4), 3.24 (t, J = 11.0 Hz, 1H, H5), 2.78-2.70 
(m, 1H, H3), 2.46 (s, 3H), 1.21 (s, 3H, H6); minor diastereoisomer 
7.81 (d, J = 8.0 Hz, 2H), 7.34-7.21 (m, 3H), 7.12 (d, J = 8.0 Hz, 
2H), 3.74-3.70 (m, 1H, H4’), 3.69 (d, J = 9.7 Hz, 1H, H1’), 3.49-
3.43 (m, 3H, H1’, H4’, H5’), 3.17-3.13 (m, 1H, H5’), 2.45 (s, 3H), 
2.41-2.38 (m, 1H, H3’), 1.35 (s, 3H, H6’); 13C NMR (CDCl3) δ 
major diastereoisomer 143.7, 142.9, 133.8, 129.8, 128.8, 127.5, 
127.1, 125.6, 61.7 (C1), 51.1 (C4), 50.3 (C3), 47.4 (C2), 42.9 (C5), 
21.6, 19.7 (C6); minor diastereoisomer 143.7, 141.8, 133.8, 129.8, 
128.8, 127.4, 127.0, 126.1, 57.7 (C1’), 50.8 (C3’), 50.3 (C4’), 48.5 
(C2’), 43.9 (C5’), 28.1 (C6’), 21.6; FTIR (νmax cm
-1) 2921 (sp3 C-
H), 2858 (sp3 C-H), 1343 (sulfone), 1159 (sulfone); HRMS 
(ESI+) calculated for C19H22ClNO2SNa [M+Na]
+ 386.0942, found 
386.0948.  
 
4-(chloromethyl)-3-(4-chlorophenyl)-3-methyl-1-tosyl 
pyrrolidine (4h). According to general procedure C1, isolated as 
a colorless oil (60.2 mg, 0.151 mmol, 76%) of a mixture of non 
separable diastereoisomers (dr = 78:22). Rf 0.51 (30% 
EtOAc/hexane); 1H NMR (CDCl3) δ major diastereoisomer 7.73 
(d, J = 8.2 Hz, 2H), 7.37-7.33 (m, 2H), 7.28-7.24 (m, 2H), 7.15 
(d, J = 8.6 Hz, 2H), 3.73 (dd, J = 10.5, 7.9 Hz, 1H, H4), 3.45-3.37 
(m, 3H, 2H1, H5), 3.29 (dd, J = 10.5, 8.7 Hz, 1H, H4), 3.20 (t, 
J = 11.0 Hz, 1H, H5), 2.70-2.63 (m, 1H, H3), 2.45 (s, 3H), 1.17 (s, 
3H, H6); minor diastereoisomer 7.78 (d, J = 8.2 Hz, 2H), 7.37-
7.33 (m, 2H), 7.28-7.24 (m, 2H), 7.06 (d, J = 8.6 Hz, 2H), 3.71-
3.67 (m, 1H, H4’), 3.65 (d, J = 9.7 Hz, 1H, H1’), 3.45-3.37 (m, 3H, 
H1’, H4’, H5’), 3.12-3.08 (m, 1H, H5’), 2.44 (s, 3H), 2.37-2.32 (m, 
1H, H3’), 1.32 (s, 3H, H6’); 13C NMR (CDCl3) δ major 
diastereoisomer 143.8, 141.5, 133.7, 133.0, 129.8, 128.8, 127.4, 
127.1, 61.5 (C1), 51.0 (C4), 50.4 (C3), 47.1 (C2), 42.6 (C5), 21.6, 
19.6 (C6); minor diastereoisomer 143.9, 140.3, 133.7, 133.0, 
129.9, 128.9, 127.7, 127.4, 58.0 (C1’), 50.7 (C3’), 50.4 (C4’), 48.1 
(C2’), 43.5 (C5’), 27.7 (C6’), 21.6; FTIR (νmax cm
-1) 2972 (sp3 C-
H), 2926 (sp3 C-H), 2881 (sp3 C-H), 1343 (sulfone), 1154 
(sulfone); HRMS (ESI+) calculated for C19H21Cl2NO2SNa 
[M+Na]+ 420.0562, found 420.0553. 
 
4-(chloromethyl)-3-(4-fluorophenyl)-3-methyl-1-tosyl 
pyrrolidine (4i). According to general procedure C1, isolated as a 
  
colorless oil (56.0 mg, 0.147 mmol, 73%) of a mixture of non 
separable diastereoisomers (dr = 78:22). Rf 0.40 (25% 
EtOAc/hexane); 1H NMR (CDCl3) δ major diastereoisomer 7.74 
(d, J = 8.3 Hz, 2H), 7.37-7.35 (m, 2H), 7.21-7.19 (m, 2H), 7.01-
6.97 (m, 2H), 3.75 (dd, J = 10.4, 7.8 Hz, 1H, H4), 3.45-3.40 (m, 
3H, 2H1, H5), 3.31 (dd, J = 10.4, 8.8 Hz, 1H, H4), 3.22 (t, 
J = 11.0 Hz, 1H, H5), 2.68 (dtd, J = 11.0, 8.4, 4.0 Hz, 1H, H3), 
2.46 (s, 3H), 1.19 (s, 3H, H6); minor diastereoisomer 7.79 (d, 
J = 8.3 Hz, 2H), 7.37-7.35 (m, 2H), 7.12-7.09 (m, 2H), 7.01-6.97 
(m, 2H), 3.71 (dd, J = 10.4, 7.8 Hz, 1H, H4’), 3.67 (d, J = 10.0 Hz, 
1H, H1’), 3.45-3.40 (m, 3H, H1’, H4’, H5’), 3.12 (dd, J = 11.0, 
4.0 Hz, 1H, H5’), 2.45 (s, 3H), 2.38-2.32 (m, 1H, H3’), 1.34 (s, 3H, 
H6’); 13C NMR (CDCl3) δ major diastereoisomer 161.6 (d, 
J = 247 Hz), 143.8, 138.7 (d, J = 3 Hz), 133.7, 129.8, 127.4, 127.3 
(d, J = 8 Hz), 115.5 (d, J = 21 Hz), 61.6 (C1), 51.0 (C4), 42.7 (C5), 
21.6, 19.7 (C6); minor diastereoisomer 143.7, 137.5 (d, J = 3 Hz), 
133.7, 129.9, 127.8 (d, J = 8 Hz), 127.4, 115.7 (d, J = 21 Hz), 
58.2 (C1’), 50.8 (C4’), 43.6 (C5’), 27.8 (C6’), 21.6; 19F NMR 
(CDCl3) δ -116.2, -116.4; FTIR (νmax cm
-1) 2968 (sp3 C-H), 2880 
(sp3 C-H), 1341 (sulfone), 1153 (sulfone); HRMS (ESI+) 
calculated for C19H22ClNO2SF [M+H]
+ 382.1038, found 
382.1026.  
 
4'-(chloromethyl)-1'-tosyl-3,4-dihydro-2H-spiro[naphthalene-
1,3'-pyrrolidine] (4j). According to general procedure C1, 
isolated as an off-white solid (44 mg, 0.113 mmol, 56%) of a 
mixture of non separable diastereoisomers (dr = 76:24). With 
general procedure C2 (39.5 mg, 0.101 mmol, 51%). Rf 0.51 (30% 
EtOAc/hexane); 1H NMR (CDCl3) δ major diastereoisomer 7.78-
7.74 (m, 2H), 7.40-7.35 (m, 2H), 7.15-7.03 (m, 4H), 3.87 (dd, 
J = 10.3, 7.9 Hz, 1H, H4), 3.62 (d, J = 10.3 Hz, 1H, H1), 3.33-3.24 
(m, 3H, H4, 2H5), 3.23 (d, J = 10.3 Hz, 1H, H1), 2.91-2.85 (m, 1H, 
H3), 2.73-2.66 (m, 2H, 2H8), 2.47 (s, 3H), 1.76-1.69 (m, 1H, H7), 
1.67-1.56 (m, 1H, H7), 1.47-1.37 (m, 2H, 2H6); minor 
diastereoisomer 7.78-7.74 (m, 2H), 7.40-7.35 (m, 2H), 7.15-7.03 
(m, 4H), 3.71 (d, J = 10.1 Hz, 1H, H1’), 3.64-3.60 (m, 1H, H4’), 
3.41 (dd, J = 10.5, 6.7 Hz, 1H, H4’), 3.17 (d, J = 10.1 Hz, 1H, 
H1’), 3.06 (dd, J = 11.0, 3.8 Hz, 1H, H5’), 2.90-2.82 (m, 1H, H5’), 
2.77 (t, J = 6.3 Hz, 2H, 2H8’), 2.48 (s, 3H), 2.45-2.41 (m, 1H, 
H3’), 1.81-1.76 (m, 3H, H6’, 2H7’), 1.76-1.69 (m, 1H, H6’); 13C 
NMR (CDCl3) δ major diastereoisomer 143.6, 138.6, 136.0, 
134.1, 129.8, 127.4, 126.9, 126.6, 125.6, 61.7 (C1), 51.0 (C3), 50.6 
(C4), 47.2 (C2), 42.6 (C5), 30.1 (C8), 27.0 (C6), 21.6, 19.7 (C7); 
minor diastereoisomer 143.8, 137.0, 136.9, 132.6, 129.6, 127.9, 
127.2, 126.9, 126.1, 62.6 (C1’), 52.6 (C4’), 52.1 (C3’), 46.1 (C5’), 
37.5 (C2’), 29.7 (C8’), 29.3 (C6’), 21.6, 20.0 (C7’); FTIR (νmax cm
-1) 
2914 (sp3 C-H), 2853 (sp3 C-H), 1340 (sulfone), 1161 (sulfone); 
HRMS (ESI+) calculated for C21H24ClNO2SNa [M+Na]
+ 
412.1109, found 412.1095. 
 
4-(chloromethyl)-2-methyl-3-phenyl-1-tosylpyrrolidine (4k). 
According to general procedure C1, from the E-β-methylstyrene, 
isolated as a colorless oil (56.3 mg, 0.155 mmol, 77%) of a 
mixture of non separable diastereoisomers (dr = 67:33). With Z-β-
methylstyrene (49.8 mg, 0.137 mmol, 68%). Rf 0.49 (30% 
EtOAc/hexane); 1H NMR (CDCl3) δ major diastereoisomer 7.81 
(d, J = 8.0 Hz, 2H), 7.43-7.39 (m, 2H), 7.29-7.23 (m, 2H), 7.11 (t, 
J = 7.2 Hz, 1H), 6.90 (d, J = 7.2 Hz, 2H), 3.95-3.89 (m, 1H, H4), 
3.63 (dq, J = 9.2, 6.1 Hz, 1H, H1), 3.40 (dd, J = 11.8, 10.5 Hz, 1H, 
H4), 3.35 (dd, J = 11.4, 3.5 Hz, 1H, H5), 3.20 (dd, J = 11.4, 7.6 
Hz, 1H, H5), 2.66 (dd, J = 9.2, 1.3 Hz, 1H, H2), 2.50 (s, 3H), 2.12-
2.02 (m, 1H, H3), 1.37 (d, J = 6.2 Hz, 3H, H6); minor 
diastereoisomer 7.84 (d, J = 8.0 Hz, 2H), 7.43-7.39 (m, 2H), 7.29-
7.23 (m, 2H), 7.18 (t, J = 7.2 Hz, 1H), 6.66 (d, J = 7.2 Hz, 2H), 
3.95-3.89 (m, 1H, H1’), 3.76 (dd, J = 10.2, 6.6 Hz, 1H, H4’), 3.30 
(dd, J = 10.2, 8.0 Hz, 1H, H4’), 3.16 (dd, J = 7.1, 4.4 Hz, 1H, H2’), 
2.92 (dd, J = 10.8, 5.9 Hz, 1H, H5’), 2.88-2.79 (m, 1H, H3’), 2.60 
(dd, J = 10.8, 9.3 Hz, 1H, H5’), 2.51 (s, 3H), 1.49 (d, J = 6.2 Hz, 
3H, H6’); 13C NMR (CDCl3) δ major diastereoisomer 143.7, 
137.7, 135.1, 129.8, 129.0, 128.6, 127.7, 127.5, 63.9 (C1), 57.0 
(C2), 52.3 (C4), 46.7 (C3), 43.7 (C5), 21.6, 20.6 (C6); minor 
diastereoisomer 143.6, 137.8, 135.1, 129.9, 127.9, 127.7, 127.5, 
127.3, 61.2 (C1’), 54.7 (C2’), 51.1 (C4’), 44.1 (C3’), 43.0 (C5’), 23.1 
(C6’), 21.6; FTIR (νmax cm
-1) 2967 (sp3 C-H), 2924 (sp3 C-H), 
1343 (sulfone), 1161 (sulfone); HRMS (ESI+) calculated for 
C19H22ClNO2SNa [M+Na]
+ 386.0951, found 386.0944. 
 
4-(chloromethyl)-3-(2-methoxyphenyl)-2-methyl-1-
tosylpyrrolidine (4l). According to general procedure C1, 
isolated as a white solid (65.3 mg, 0.166 mmol, 83%) of a mixture 
of separable diastereoisomers (dr = 62:38). Analyses for major 
diastereoisomer (white solid). Rf 0.55 (30% EtOAc/hexane); 
1H 
NMR (CDCl3) δ 7.79 (d, J = 8.0 Hz, 2H), 7.38 (d, J = 8.0 Hz, 
2H), 7.20 (ddd, J = 8.8, 7.5, 1.7 Hz, 1H), 6.86-6.80 (m, 2H), 6.77 
(dd, J = 7.5, 1.7 Hz, 1H), 3.86 (dd, J = 11.5, 7.5 Hz, 1H, H4), 3.73 
(dq, J = 9.3, 6.2 Hz, 1H, H1), 3.64 (s, 3H, OMe), 3.38 (dd, 
J = 11.5, 9.8 Hz, 1H, H4), 3.33 (dd, J = 11.2, 3.9 Hz, 1H, H5), 
3.24 (dd, J = 11.2, 8.6 Hz, 1H, H5), 3.06 (dd, J = 10.9, 9.3 Hz, 1H, 
H2), 2.48 (s, 3H), 2.36-2.28 (m, 1H, H3), 1.34 (d, J = 6.2 Hz, 3H, 
H6); 13C NMR (CDCl3) δ 157.6, 143.4, 135.1, 129.7, 128.8, 128.6, 
127.7, 125.6, 120.9, 110.9, 62.1 (C1), 55.1 (OMe), 52.8 (C4), 51.6 
(C2), 45.1 (C3), 44.8 (C5), 21.6, 21.0 (C6); FTIR (νmax cm
-1) 2964 
(sp3 C-H), 2921 (sp3 C-H), 2848 (sp3 C-H), 1333 (sulfone), 1245 
(ether C-O), 1164 (sulfone); HRMS (ESI+) calculated for 
C20H24ClNO3SNa [M+Na]
+ 416.1054, found 416.1050; M.p.: 
105-107 °C. Analyses for minor diastereoisomer (white solid). Rf 
0.60 (30% EtOAc/hexane); 1H NMR (CDCl3) δ 7.84 (d, J = 8.0 
Hz, 2H), 7.38 (d, J = 8.0 Hz, 2H), 7.17 (ddd, J = 8.2, 7.4, 1.7 Hz, 
1H), 6.81 (dd, J = 8.2, 1.2 Hz, 1H), 6.66 (td, J = 7.4, 1.2 Hz, 1H), 
6.42 (d, J = 7.4 Hz, 1H), 3.91 (p, J = 6.7 Hz, 1H, H1’), 3.81-3.88 
(m 1H, H4’), 3.76 (s, 3H, OMe), 3.59 (t, J = 6.7 Hz, 1H, H2’), 3.42 
(dd, J = 10.6, 6.1 Hz, 1H, H4’), 3.06 (dd, J = 11.2, 4.1 Hz, 1H, 
H5’), 2.89-2.78 (m, 1H, H3’), 2.35 (t, J = 11.2 Hz, 1H, H5’), 2.48 
(s, 3H), 1.46 (d, J = 6.2 Hz, 3H, H6’); 13C NMR (CDCl3) 157.1, 
143.5, 135.1, 129.8, 128.2, 127.5, 125.4, 120.5, 110.3, 59.5 (C1’), 
55.2 (OMe), 51.6 (C4’), 43.6 (C5’), 42.9 (C3’), 22.6 (C6’), 21.6. C2’ 
was not observed; FTIR (νmax cm
-1) 2970 (sp3 C-H), 2924 (sp3 C-
H), 2851 (sp3 C-H), 1346 (sulfone), 1245 (ether C-O), 1162 
(sulfone); HRMS (ESI+) calculated for C20H24ClNO3SNa 
[M+Na]+ 416.1054, found 416.1058; M.p.: 114-116 °C. 
 
4-(chloromethyl)-3-(4-methoxyphenyl)-2-methyl-1-tosyl 
pyrrolidine (4m). According to general procedure C1, isolated as 
a clear yellow oil (71.5 mg, 0.182 mmol, 91%) of a mixture of 
non separable diastereoisomers (dr = 63:37). With general 
procedure C2 (68.8 mg, 0.175 mmol, 87%). Rf 0.35 (30% 
  
EtOAc/hexane); 1H NMR (CDCl3) δ major diastereoisomer 7.79 
(d, J = 8.0 Hz, 2H), 7.39 (d, J = 8.0 Hz, 2H), 6.83-6.77 (m, 4H), 
3.91-3.85 (m, 1H, H4), 3.77 (s, 3H, OMe), 3.54 (dq, J = 9.2, 
6.2 Hz, 1H, H1), 3.40-3.31 (m, 2H, H4, H5), 3.18 (dd, J = 11.4, 7.6 
Hz, 1H, H5), 2.60 (dd, J = 11.7, 9.2 Hz, 1H, H2), 2.48 (s, 3H), 
2.03-1.95 (m, 1H, H3), 1.35 (d, J = 6.2 Hz, 3H, H6); minor 
diastereoisomer 7.82 (d, J = 8.0 Hz, 2H), 7.39 (d, J = 8.0 Hz, 2H), 
6.63 (d, J = 8.9 Hz, 2H), 6.57 (d, J = 8.9 Hz, 2H), 3.91-3.85 (m, 
1H, H1’), 3.74-3.70 (m, 1H, H4’), 3.74 (s, 3H, OMe), 3.27 (dd, 
J = 10.2, 8.0 Hz, 1H, H4’), 3.10 (dd, J = 7.1, 4.4 Hz, 1H, H2’), 
2.92 (dd, J = 10.8, 5.9 Hz, 1H, H5’), 2.85-2.74 (m, 1H, H3’), 2.60 
(dd, J = 11.7, 9.6 Hz, 1H, H5’), 2.49 (s, 3H), 1.46 (d, J = 6.2 Hz, 
3H, H6’); 13C NMR (CDCl3) δ major diastereoisomer 159.1, 
143.7, 135.1, 129.8, 129.4, 128.7, 127.5, 114.4, 63.9 (C1), 56.3 
(C2), 55.3 (OMe), 52.2 (C4), 46.6 (C3), 43.7 (C5), 21.6, 20.5 (C6); 
minor diastereoisomer 158.6, 143.6, 135.1, 129.9, 129.6, 128.9, 
127.5, 113.9, 61.4 (C1’), 55.2 (OMe), 53.9 (C2’), 51.1 (C4’), 44.1 
(C3’), 43.1 (C5’), 23.0 (C6’), 21.6; FTIR (νmax cm
-1) 2964 (sp3 C-
H), 2929 (sp3 C-H), 1343 (sulfone), 1247 (ether C-O), 1141 
(sulfone); HRMS (ESI+) calculated for C20H24ClNO3SNa 
[M+Na]+ 416.1058, found 416.1049. 
 
4-(chloromethyl)-2-methyl-3-(5-phenylthiophen-2-yl)-1-
tosylpyrrolidine (4n). According to general procedure C1, 
isolated as an orange oil (62.1 mg, 0.139 mmol, 70%) of a 
mixture of non separable diastereoisomers (dr = 65:35). With 
general procedure C2 (50.1 mg, 0.112 mmol, 56%). Rf 0.43 (30% 
EtOAc/hexane); 1H NMR (CDCl3) δ major diastereoisomer 7.80 
(d, J = 8.0 Hz, 2H), 7.50 (d, J = 7.6 Hz, 2H), 7.42-7.33 (m, 3H), 
7.30-7.25 (m, 2H), 7.10 (d, J = 3.6 Hz, 1H), 6.71 (d, J = 3.6 Hz, 
1H), 3.89-3.8 (m, 1H, H4), 3.65 (dq, J = 9.0, 6.2 Hz, 1H, H1), 3.51 
(dd, J = 11.5, 3.5 Hz, 1H, H5), 3.46-3.39 (m, 1H, H4), 3.34 (dd, 
J = 11.5, 7.2 Hz, 1H, H5), 3.01 (dd, J = 11.1, 9.0 Hz, 1H, H2), 
2.48 (s, 3H), 2.07-1.99 (m, 1H, H3), 1.48 (d, J = 6.2 Hz, 3H, H6); 
minor diastereoisomer 7.83 (d, J = 8.0 Hz, 2H), 7.42-7.33 (m, 
6H), 7.30-7.25 (m, 1H), 7.01 (d, J = 3.6 Hz, 1H), 6.50 (d, 
J = 3.6 Hz, 1H), 3.89-3.82 (m, 1H, H1’), 3.80 (dd, J = 9.9, 5.8 Hz, 
1H, H4’), 3.32-3.28 (m, 1H, H4’), 3.46-3.39 (m, 1H, H2’),3.14-3.09 
(m, 1H, H5’), 2.90-2.85 (m, 2H, H3’, H5’), 2.45 (s, 3H), 1.54 (d, 
J = 6.2 Hz, 3H, H6’); 13C NMR (CDCl3) δ major diastereoisomer 
143.8, 143.6, 140.5, 134.8, 133.9, 129.9, 128.9, 127.8, 127.6, 
126.8, 125.6, 122.9, 64.2 (C1), 52.0 (C2), 51.9 (C4), 47.4 (C3), 
43.5 (C5), 21.6, 20.8 (C6); minor diastereoisomer 143.7, 143.6, 
139.7, 134.8, 133.8, 129.8, 128.9, 127.7, 127.1, 126.4, 125.5, 
122.5, 62.7 (C1’), 50.5 (C2’ or C4’), 50.4 (C2’ or C4’), 43.8 (C3’), 
42.6 (C5’), 23.2 (C6’), 21.6; FTIR (νmax cm
-1) 2962 (sp3 C-H), 
2924 (sp3 C-H), 2851 (sp3 C-H), 1341 (sulfone), 1161 (sulfone); 
HRMS (ESI+) calculated for C23H25ClNO2S2 [M+H]
+ 446.1010, 
found 446.0999. 
 
4-(chloromethyl)-3-phenyl-1-tosylpyrrolidin-2-yl)methanol 
(4o). According to general procedure C1, isolated as an colorless 
oil (37.2 mg, 0.098 mmol, 49%) of a mixture of non separable 
diastereoisomers (dr = 53:47). With general procedure C2 (41 mg, 
0.108 mmol, 54%). Rf 0.27 (30% EtOAc/hexane); 
1H NMR 
(CDCl3) δ major diastereoisomer 7.83 (d, J = 7.8 Hz, 2H), 7.44 
(t, J = 6.9 Hz, 2H), 7.25-7.21 (m, 3H), 6.80 (dd, J = 6.0, 2.7 Hz, 
2H), 4.04-3.98 (m, 1H, H4), 3.63-3.55 (m, 2H, H1, H6), 3.87 (d, 
J = 11.4 Hz, 1H, H6), 3.40 (t, J = 11.5 Hz, 1H, H4), 3.36-3.31 (m, 
1H, H5), 3.20 (dd, J = 11.4, 8.1 Hz, 1H, H5), 2.79 (br s, 1H, OH), 
2.98 (dd, J = 11.4, 9.0 Hz, 1H, H2), 2.52 (s, 3H), 2.03-1.96 (m, 
1H, H3); minor diastereoisomer 7.85 (d, J = 7.8 Hz, 2H), 7.44 (t, 
J = 6.9 Hz, 2H), 7.17 (t, J = 7.4 Hz, 1H), 7.05 (t, J = 7.4 Hz, 2H), 
6.58 (d, J = 7.6 Hz, 2H), 3.94 (d, J = 9.8 Hz, 1H, H6’), 3.84-3.75 
(m, 3H, H1’, H4’, H6’), 3.50 (dd, J = 7.2, 5.1 Hz, 1H, H2’), 3.36-
3.31 (m, 1H, H4’), 2.90 (dd, J = 10.6, 5.6 Hz, 1H, H5’), 2.70 (br s, 
1H, OH), 2.87-2.81 (m, 1H, H3’), 2.52 (s, 3H), 2.44 (t, 
J = 10.6 Hz, 1H, H5’); 13C NMR (CDCl3) δ major diastereoisomer 
144.3, 135.5, 134.2, 130.1, 129.1, 127.8, 127.8, 127.7, 69.7 (C1), 
63.1 (C6), 53.6 (C4), 50.7 (C2), 46.9 (C3), 43.4 (C5), 21.6; minor 
diastereoisomer 144.4, 135.4, 133.8, 130.1, 128.7, 127.9, 127.8, 
127.4, 66.9 (C1’), 65.4 (C6’), 52.3 (C4’), 50.0 (C2’), 44.4 (C3’), 42.9 
(C5’), 21.6; FTIR (νmax cm
-1) 3487 (OH), 2926 (sp3 C-H), 2871 
(sp3 C-H), 1335 (sulfone), 1154 (sulfone); HRMS (ESI+) 
calculated for C19H23ClNO3S [M+H]
+ 380.1082, found 380.1074. 
 
3-(chloromethyl)-1-tosyl-1,2,3,3a,8,8a-hexahydroindeno[2,1-
b]pyrrole (4p). According to general procedure C1, isolated as a 
yellow oil (51.5 mg, 0.142 mmol, 71%) of a mixture of non 
separable diastereoisomers (dr = 60:40). With general procedure 
C2 (56.2 mg, 0.155 mmol, 78%). Rf 0.44 (30% EtOAc/hexane); 
1H NMR (CDCl3) δ major diastereoisomer 7.79-7.74 (m, 2H), 
7.36 (d, J = 7.9 Hz, 2H), 7.24-7.15 (m, 4H), 4.45 (dt, J = 8.0, 
5.4 Hz, 1H, H1), 3.89 (t, J = 7.7 Hz, 1H, H2), 3.52-3.46 (m, 1H, 
H4), 3.36-3.29 (m, 4H, 2H5, 2H6), 3.20 (dd, J = 10.9, 7.7 Hz, 1H, 
H4), 2.46 (s, 3H), 2.44-2.39 (m, 1H, H3); minor diastereoisomer 
7.79-7.74 (m, 2H), 7.36 (d, J = 7.9 Hz, 2H), 7.24-7.15 (m, 4H), 
4.37 (dt, J = 6.9, 2.3 Hz, 1H, H1’), 3.57 (dd, J = 7.2, 3.5 Hz, 1H, 
H2’), 3.45-3.37 (m, 2H, H4’, H6’), 3.36-3.29 (m, 1H, H6’), 3.29-
3.24 (m, 2H, H4’, H5’), 2.97 (dd, J = 11.1, 8.4 Hz, H, H5’), 2.64-
2.59 (m, 1H, H3’), 2.45 (s, 3H); 13C NMR (CDCl3) δ major 
diastereoisomer 143.7, 143.3, 137.9, 134.6, 129.8, 128.0, 127.5, 
126.9, 125.3, 123.5, 64.0 (C1), 52.3 (C2), 52.2 (C4), 44.8 (C3), 
43.2 (C6), 40.9 (C5), 21.6; minor diastereoisomer 143.7, 141.7, 
141.4, 134.7, 129.8, 127.9, 127.4, 127.0, 125.3, 123.5, 63.3 (C1’), 
53.7 (C2’), 51.8 (C4’), 47.1 (C3’), 45.1 (C5’), 40.7 (C6’), 21.6; FTIR 
(νmax cm
-1) 2912 (sp3 C-H), 2853 (sp3 C-H), 1338 (sulfone), 1154 
(sulfone); HRMS (ESI+) calculated for C19H20ClNO2SNa 
[M+Na]+ 384.0795, found 384.0791. 
 
1-(chloromethyl)-3-tosyl-2,3,3a,4,5,9b-hexahydro-1H-
benzo[e]indole (4q). According to general procedure C1, isolated 
as a clear yellow oil (27.6 mg, 0.073 mmol, 37%) of a mixture of 
non separable diastereoisomers (dr = 81:19). Rf 0.46 (30% 
EtOAc/hexane); 1H (CDCl3) δ for major diastereoisomer 7.78 (d, 
J = 8.0 Hz, 2H), 7.35 (d, J = 8.0 Hz, 2H), 7.18-7.10 (m, 3H), 6.99 
(d, J = 6.9 Hz, 1H), 3.99 (td, J = 7.9, 4.5 Hz, 1H, H1), 3.62 (dd, 
J = 10.0, 6.9 Hz, 1H, H4), 3.57 (dd, J = 11.5, 3.9 Hz, 1H, H5), 
3.43 (dd, J = 11.5, 6.3 Hz, 1H, H5), 3.19 (t, J = 9.4 Hz, 1H, H4), 
2.91 (t, J = 8.2 Hz, 1H, H2), 2.89-2.83 (m, 1H, H7), 2.76-2.70 (m, 
1H, H7), 2.50-2.46 (m, 1H, H3), 2.45 (s, 3H), 2.21-2.14 (m, 1H, 
H6), 2.06-1.99 (m, 1H, H6); minor diastereoisomer 7.78 (d, 
J = 8.0 Hz, 2H), 7.35 (d, J = 8.0 Hz, 2H), 7.18-7.10 (m, 3H), 7.05 
(d, J = 6.9 Hz, 1H), 3.86 (td, J = 9.7, 4.5 Hz, 1H, H1’), 3.67-3.63 
(m, 1H, H4’), 3.35 (t, J = 8.3 Hz, 1H, H2’), 3.32-3.24 (m, 2H, H3’, 
H4’), 2.83-2.77 (m, 1H, H7’), 2.69-2.64 (m, 1H, H7’), 2.45 (s, 3H), 
2.40-2.35 (m, 1H, H6’), 1.75-1.67 (m, 1H, H6’); 13C NMR (CDCl3) 
δ major diastereoisomer 143.7, 137.1, 134.6, 133.9, 129.8, 128.9, 
  
128.6, 127.6, 126.9, 126.3, 58.9 (C1), 50.6 (C4), 46.6 (C3), 44.0 
(C5), 43.4 (C2),  29.0 (C6), 27.0 (C7), 21.6; minor diastereoisomer 
143.8, 137.7, 134.6, 133.9, 129.8, 129.0, 128.7, 127.7, 126.7, 
126.6, 58.8 (C1’), 51.6 (C4’), 46.0 (C3’), 44.3 (C5’), 43.9 (C2’),  
30.0 (C6’), 27.6 (C7’), 21.6; FTIR (νmax cm
-1) 2931 (sp3 C-H), 
2853 (sp3 C-H), 1335 (sulfone), 1159 (sulfone); HRMS (ESI+) 
calculated for C20H22ClNO2SNa [M+Na]
+ 398.0952, found 
398.0949. 
 
3-(chloromethyl)-1-tosyl-2,3,3a,8a-tetrahydro-1H-
benzofuro[2,3-b]pyrrole (4r). A 10 mL microwave vial was 
charged with the amine 2a (0.2 mmol, 1.0 equiv.), benzofuran 
(0.4 mmol, 2 equiv.), Ir(dF(CF3)2ppy)2(bpy)PF6 (0.001 mol, 
0.5 mol%) and CH2Cl2 (4 mL, 0.05 M). The reaction mixture was 
stirred at 35 °C under blue LEDs irradation (450 nm, 14.4 W) for 
1 h. The crude was concentrated in vacuo and purified by 
Florisil® flash column chromatography to yield the desired 
pyrrolidine 4r as an off-white solid (48.1 mg, 0.132 mmol, 66%) 
of a mixture of two diastereoisomers (dr = 84:16). With the same 
conditions using CAT-4 (0.001 mol, 0.5 mol%) as the 
photocatalyst (34.1 mg, 0.094 mmol, 47%). Rf 0.44 (30% 
EtOAc/hexane); 1H NMR (CDCl3) δ major diastereoisomer 7.84 
(d, J = 8.3 Hz, 2H), 7.33-7.25 (m, 3H), 7.16-7.09 (m, 1H), 6.89-
6.84 (m, 1H), 6.70-6.65 (m, 1H), 6.54 (d, J = 6.8 Hz, 1H, H1), 
4.26 (t, J = 7.5 Hz, 1H, H2), 3.76 (dd, J = 9.6, 6.8 Hz, 1H, H4), 
3.61 (dd, J = 11.1, 8.2 Hz, 1H, H5), 3.41 (dd, J = 11.1, 7.3 Hz, 1H, 
H5), 2.98-2.89 (m, 1H, H3), 2.62 (dd, J = 11.4, 9.6 Hz, 1H, H4), 
2.42 (s, 3H); minor diastereoisomer 7.84 (d, J = 8.3 Hz, 2H), 
7.33-7.25 (m, 3H), 7.16-7.09 (m, 1H), 6.89-6.84 (m, 1H), 6.70-
6.65 (m, 1H), 6.45 (d, J = 6.8 Hz, 1H, H1’), 4.01 (d, J = 6.8 Hz, 
1H, H2’), 3.58-3.51 (m, 3H, H3’, H4’, H5’), 3.11 (dd, J = 10.5, 
5.7 Hz, 1H, H5’), 2.62 (dd, J = 11.4, 9.6 Hz, 1H, H4’), 2.42 (s, 
3H); 13C NMR (CDCl3) δ major diastereoisomer 159.7, 143.8, 
136.3, 129.5, 129.2, 127.8, 125.9, 121.7, 121.1, 109.7, 96.1 (C1), 
48.9 (C4), 48.7 (C2), 45.5 (C3), 42.0 (C5), 21.6; minor 
diastereoisomer 158.6, 143.8, 136.2, 129.5, 129.2, 127.8, 126.0, 
124.4, 121.5, 109.6, 95.0 (C1’), 50.6 (C4’), 48.8 (C2’), 45.8 (C3’), 
42.0 (C5’), 21.6; FTIR (νmax cm
-1) 2926 (sp3 C-H), 2859 (sp3 C-H), 
1346 (sulfone), 1222 (ether C-O), 1159 (sulfone); HRMS (ESI+) 
calculated for C18H18ClNO3SNa [M+Na]
+ 386.0588, found 
386.0584. 
 
8-(tert-butyl)-4-(chloromethyl)-2-tosyl-2-azaspiro[4.5]decane 
(4s). According to general procedure C1, isolated as a white solid 
(46.3 mg, 0.116 mmol, 58%). Rf 0.59 (30% EtOAc/hexane); 
1H NMR (CDCl3) δ  7.72 (d, J = 8.0 Hz, 2H), 7.33 (d, J = 8.0 Hz, 
2H), 3.62 (d, J = 11.0 Hz, 1H, H4), 3.48-3.43 (m, 2H, H4, H5), 
3.01 (d, J = 9.8 Hz, 1H, H1), 2.91 (d, J = 9.8 Hz, 1H, H1), 2.74 (t, 
J = 11.1 Hz, 1H, H5), 2.44 (s, 3H), 2.30-2.26 (m, 1H, H3), 1.66-
1.63 (m, 1H, H6 or H7), 1.60-1.57 (m, 1H, H6 or H7), 1.57-1.54 
(m, 1H, H6 or H7), 1.49-1.46 (m, 1H, H6 or H7), 1.20 (td, J = 13.7, 
3.6 Hz, 1H, H6 or H7), 1.04-1.02 (m, 2H, 2H6 or H7), 0.98-0.92 
(m, 1H, H8), 0.88-0.84 (m, 1H, H6 or H7), 0.81 (s, 9H, H10); 13C 
NMR (CDCl3) δ 143.5, 133.6, 129.6, 127.4, 59.1 (C
1), 49.8 (C4), 
47.6 (C8), 44.6 (C2), 44.0 (C5), 43.9 (C3), 36.7 (C6 or C7), 32.3 
(C9), 30.4 (C6 or C7), 27.4 (C10), 24.0 (C6 or C7), 23.2 (C6 or C7), 
21.6; FTIR (νmax cm
-1) 2942 (sp3 C-H), 2951 (sp3 C-H), 1338 
(sulfone), 1156 (sulfone); HRMS (ESI+) calculated for 
C21H33NO2SCl [M+H]
+ 398.1921, found 398.1922; M.p.: 140-
142 °C. 
 
4-(chloromethyl)-2,3,3-trimethyl-1-tosylpyrrolidine (4t). 
According to general procedure C1 and using 10 equiv. of 2-
methylbut-2-ene, isolated as a colorless oil (42.3 mg, 0.134 mmol, 
67%) of a mixture of non separable diastereoisomers (dr = 53:47). 
With general procedure C2 (46.7 mg, 0.148 mmol, 74%). Rf 0.44 
(30% EtOAc/hexane); 1H NMR (CDCl3) δ major diastereoisomer 
7.74-7.69 (m, 2H), 7.35-7.29 (m, 2H), 3.76-3.67 (m, 1H, H4), 
3.50-3.45 (m, 1H, H5), 3.28 (t, J = 10.7 Hz, 1H, H5), 3.19 (t, 
J = 11.0 Hz, 1H, H4), 2.99 (q, J = 6.4 Hz, 1H, H1), 2.44 (s, 3H), 
1.65-1.58 (m, 1H, H3), 1.29 (d, J = 6.5 Hz, 3H, H6), 0.84 (s, 3H, 
H7 or H8), 0.76 (s, 3H, H7 or H8); minor diastereoisomer 7.74-
7.69 (m, 2H), 7.35-7.29 (m, 2H), 3.76-3.67 (m, 1H, H4’), 3.50-
3.45 (m, 1H, H5’), 3.37 (q, J = 6.4 Hz, 1H, H1’), 3.08 (t, 
J = 11.0 Hz, 1H, H5’), 2.94 (t, J = 9.8 Hz, 1H, H4’), 2.42 (s, 3H), 
2.39-2.29 (m, 1H, H3’), 1.23 (d, J = 6.5 Hz, 3H, H6’) 0.94 (s, 3H, 
H7’ or H8’), 0.37 (s, 3H, H7’ or H8’); 13C NMR (CDCl3) δ major 
diastereoisomer 143.5, 133.9, 129.7, 127.5, 66.4 (C1), 52.0 (C4), 
49.7 (C3), 43.6 (C2), 42.8 (C5), 24.8 (C7 or C8), 21.6, 15.7 (C6), 
15.6 (C7 or C8); minor diastereoisomer 143.3, 134.7, 129.6, 
127.3, 66.6 (C1’), 50.7 (C4’), 48.0 (C3’), 43.0 (C2’), 42.9 (C5’), 22.2 
(C7’ or C8’), 21.5, 21.5 (C7’ or C8’), 18.9 (C6’); FTIR (νmax cm
-1) 
2972 (sp3 C-H), 2921 (sp3 C-H), 1338 (sulfone), 1156 (sulfone); 
HRMS (ESI+) calculated for C15H22ClNO2SNa [M+Na]
+ 
338.0952, found 338.0946. 
 
3-(chloromethyl)-1-tosyloctahydropyrano[3,2-b]pyrrole (4u). 
According to general procedure C1 and using 10 equiv. of 3,4-
dihydro-2H-pyran, a mixture of diastereoisomers was observed 
(dr = 85:15) and the major diastereoisomer was isolated as a 
colorless oil (28.4 mg, 0.086 mmol, 43%). Rf 0.39 (30% 
EtOAc/hexane); 1H NMR for major diastereoisomer (CDCl3) δ 
7.71 (d, J = 8.2 Hz, 2H), 7.33 (d, J = 8.2 Hz, 2H), 3.93-3.89 (m, 
1H, H8), 3.88 (t, J = 3.1 Hz, 1H, H2), 3.70 (dd, J = 10.8, 8.0 Hz, 
1H, H4), 3.59 (dd, J = 10.8, 7.8 Hz, 1H, H5), 3.40-3.29 (m, 4H, 
H1, H4, H5, H8), 2.62 (dt, J = 14.5, 4.9 Hz, 1H, H6), 2.44 (s, 3H), 
1.88-1.79 (m, 2H, H3, H7), 1.69 (tt, J = 13.6, 4.0 Hz, 1H, H6), 1.37 
(dd, J = 13.6, 2.2 Hz, 1H, H7); 13C NMR for major 
diastereoisomer (CDCl3) δ 143.6, 134.2, 129.8, 127.4, 76.3 (C
2), 
66.6 (C8), 59.4 (C1), 51.8 (C4), 45.5 (C3), 40.6 (C5), 26.2 (C6), 
21.5, 20.2 (C7); FTIR (νmax cm
-1) 2952 (sp3 C-H), 2922 (sp3 C-H), 
2899 (sp3 C-H), 2853 (sp3 C-H), 1336 (ether C-O and sulfone), 
1159 (sulfone); HRMS (ESI+) calculated for C15H21ClNO3S 
[M+H]+ 330.0931, found 330.0923. 
 
3-(chloromethyl)-1-((4-methoxyphenyl)sulfonyl)-4-phenyl 
pyrrolidine (4v). According to general procedure C1, isolated as 
a clear yellow oil (63.3 mg, 0.173 mmol, 87%) of a mixture of 
non separable diastereoisomers (dr = 70:30). With general 
procedure C2 (66.0 mg, 0.180 mmol, 90%). Rf 0.31 (30% 
EtOAc/hexane); 1H NMR (CDCl3) δ major diastereoisomer 7.81 
(d, J = 8.9 Hz, 2H), 7.32-7.23 (m, 3H), 7.11 (d, J = 7.1 Hz, 2H), 
7.08-7.02 (m, 2H), 3.90 (s, 3H), 3.75-3.64 (m, 2H, H1, H4), 3.46 
  
(dd, J = 11.3, 4.0 Hz, 1H, H5), 3.36-3.24 (m, 3H, H1, H4, H5), 
3.05-2.98 (m, 1H, H2), 2.56-2.48 (m, 1H, H3); minor 
diastereoisomer 7.85 (d, J = 8.9 Hz, 2H), 7.32-7.23 (m, 4H), 7.08-
7.02 (m, 3H), 3.90 (s, 3H), 3.75-3.64 (m, 1H, H1’), 3.64-3.58 (m, 
2H, H1’, H4’), 3.52-3.48 (m, 1H, H2’), 3.36-3.24 (m, 1H, H4’), 
3.05-2.98 (m, 1H, H5’), 2.81 (dd, J = 11.0, 9.2 Hz, 1H, H5’), 2.66-
2.60 (m, 1H, H3’); 13C NMR (CDCl3) δ major diastereoisomer 
163.1, 138.5, 129.7, 129.0, 128.1, 127.6, 127.4, 114.4, 55.6, 54.6 
(C1), 51.3 (C4), 48.0 (C3), 47.3 (C2), 44.2 (C5); minor 
diastereoisomer 163.1, 137.5, 129.6, 128.8, 128.4, 127.8, 127.5, 
114.4, 55.5, 52.5 (C1’), 50.3 (C4’), 45.8 (C2’), 45.6 (C3’), 43.1 
(C5’); FTIR (νmax cm
-1) 2947 (sp3 C-H), 2843 (sp3 C-H), 1343 
(sulfone), 1260 (ether C-O), 1154 (sulfone); HRMS (ESI+) 
calculated for C18H20ClNO3SNa [M+Na]
+ 388.0744, found 
388.0743.  
 
3-(chloromethyl)-1-((4-nitrophenyl)sulfonyl)-4-phenyl 
pyrrolidine (4w). According to general procedure C1, isolated as 
a yellow solid (64.3 mg, 0.169 mmol, 84%) of a mixture of non 
separable diastereoisomers (dr = 70:30). Rf 0.41 (30% 
EtOAc/hexane); 1H NMR (CDCl3) δ major diastereoisomer 8.45-
8.40 (m, 2H), 8.06 (d, J = 8.5 Hz, 2H), 7.34-7.25 (m, 3H), 7.12 
(d, J = 7.4 Hz, 2H), 3.83-3.75 (m, 2H, H1, H4), 3.50 (dd, J = 11.5, 
3.6 Hz, 1H, H5), 3.40 (t, J = 10.0 Hz, 1H, H1), 3.37-3.29 (m, 2H, 
H4, H5), 3.12-3.04 (m, 1H, H2), 2.65-2.58 (m, 1H, H3); minor 
diastereoisomer 8.45-8.40 (m, 2H), 8.10 (d, J = 8.5 Hz, 2H), 7.34-
7.25 (m, 3H), 7.07 (d, J = 7.4 Hz, 2H), 3.73-3.69 (m, 2H, 2H1’), 
3.66 (dd, J = 10.6, 7.3 Hz, 1H, H4’), 3.55 (q, J = 6.5 Hz, 1H, H2’), 
3.44 (dd, J = 10.6, 6.3 Hz, 1H, H4’), 3.12-3.04 (m, 1H, H5’), 2.84 
(dd, J = 11.1, 9.2 Hz, 1H, H5’), 2.72-2.67 (m, 1H, H3’); 13C NMR 
(CDCl3) δ major diastereoisomer 150.2, 142.8, 137.4, 129.1, 
128.6, 127.9, 127.3, 124.5, 54.6 (C1), 51.1 (C4), 47.8 (C3), 47.2 
(C2), 43.7 (C5); minor diastereoisomer 150.2, 142.9, 136.8, 129.0, 
128.1, 127.7, 127.6, 124.5, 52.5 (C1’), 50.4 (C4’), 45.8 (C2’), 45.6 
(C3’), 42.8 (C5’); FTIR (νmax cm
-1) 2959 (sp3 C-H), 2888 (sp3 C-
H), 1530 (NO2), 1351 (sulfone), 1310 (NO2), 1167 (sulfone); 
HRMS (ESI+) calculated for C17H17ClN2O4SNa [M+Na]
+ 
403.0490, found 403.0478. 
 
3-(5-((-3-(chloromethyl)-4-phenylpyrrolidin-1-
yl)sulfonyl)thiophen-2-yl)-5-(trifluoromethyl)isoxazole (4x). 
According to general procedure C1, isolated as a colorless oil 
(67.0 mg, 0.141 mmol, 70%) of a mixture of non separable 
diastereoisomers (dr  = 72:28). Rf 0.36 (25% EtOAc/hexane); 
1H 1H NMR (CDCl3) δ major diastereoisomer 7.66-7.65 (m, 1H), 
7.57-7.56 (m, 1H), 7.34-7.27 (m, 3H), 7.16-7.13 (m, 2H), 7.01-
7.00 (m, 1H), 3.88-3.80 (m, 2H, H1, H4), 3.51-3.44 (m, 2H, H1, 
H5), 3.40-3.31 (m, 2H, H4, H5), 3.19-3.11 (m, 1H, H2), 2.65-2.58 
(m, 1H, H3); minor diastereoisomer 7.69-7.68 (m, 1H), 7.57-7.56 
(m, 1H), 7.34-7.27 (m, 3H), 7.16-7.13 (m, 2H), 7.01-7.00 (m, 
1H), 3.77-3.75 (m, 2H, 2H1’), 3.71-3.68 (m, 1H, H4’), 3.59-3.55 
(m, 1H, H2’), 3.51-3.44 (m, 1H, H4’), 3.09-3.05 (m, 1H, H5’), 2.93-
2.86 (m, 1H, H5’), 2.73-2.68 (m, 1H, H3’); 13C NMR (CDCl3) δ 
major diastereoisomer 156.7, 139.7, 137.5, 134.7, 132.4, 129.1, 
128.3, 129.7, 127.4, 117.5 (q, J = 270 Hz), 103.5 (q, J = 5 Hz), 
54.7 (C1), 51.4 (C4), 47.8 (C3), 47.2 (C2), 43.7 (C5); minor 
diastereoisomer when seen 159.9, 139.8, 137.4, 136.9, 132.3, 
129.0, 128.4, 127.7, 127.4, 54.9 (C1’), 50.5 (C4’), 45.9 (C2’), 45.6 
(C3’), 42.8 (C5’); 19F NMR (CDCl3) δ -65.1, -65.2; FTIR (νmax cm
-
1) 2954 (sp3 C-H), 2925 (sp3 C-H), 1343 (sulfone), 1155 
(sulfone); HRMS (ESI+) calculated for C19H17ClN2O3S2F3 
[M+H]+ 477.0316, found 477.0304. 
 
3-(chloromethyl)-4-phenylpyrrolidin-1-yl)sulfonyl)-1-methyl-
1H-imidazole (4y). According to general procedure C1, isolated 
as a bright yellow solid (39.0 mg, 0.115 mmol, 57%) of a mixture 
of non separable diastereoisomers (dr = 67:33). Rf 0.18 (2% 
MeOH/CH2Cl2);  
1H NMR (CDCl3) δ major diastereoisomer 7.54 
(d, J = 1.4 Hz, 1H), 7.50 (d, J = 1.4 Hz, 1H), 7.33-7.30 (m, 2H), 
7.27-7.22 (m, 1H), 7.19-7.17 (m, 2H), 3.96 (dd, J = 10.3, 8.0 Hz, 
1H, H1), 3.90-3.81 (m, 1H, H4), 3.78 (s, 3H), 3.59-3.54 (m, 1H, 
H1), 3.48 (dd, J = 11.3, 4.0 Hz, 1H, H5), 3.44-3.39 (m, 1H, H4), 
3.32 (dd, J = 11.3, 7.4 Hz, 1H, H5), 3.13 (td, J = 9.8, 8.0 Hz, 1H, 
H2), 2.64-2.57 (m, 1H, H3); minor diastereoisomer 7.53-7.52 (m, 
2H), 7.33-7.30 (m, 2H), 7.27-7.22 (m, 3H), 3.90-3.81 (m, 2H, 
2H1’), 3.79-3.76 (s, 4H, H4’, Me), 3.59-3.54 (m, 1H, H2’), 3.44-
3.39 (m, 1H, H4’), 3.01 (dd, J = 11.0, 6.2 Hz, 1H, H5’), 2.93 (dd, 
J = 11.0, 9.1 Hz, 1H, H5’), 2.71-2.65 (m, 1H, H3’); 13C NMR 
(CDCl3) δ major diastereoisomer 139.3, 138.4, 138.3, 128.9, 
127.9, 127.5, 124.9, 54.9 (C1), 51.6 (C4), 48.0 (C3), 47.4 (C2), 
44.2 (C5), 34.0; minor diastereoisomer 139.3, 138.3, 137.4, 128.8, 
127.5, 127.4, 124.9, 52.6 (C1’), 50.4 (C4’), 46.0 (C2’), 45.7 (C3’), 
43.1 (C5’), 34.0; FTIR (νmax cm
-1) 2980 (sp3 C-H), 1278 (sulfone), 
1160 (sulfone); HRMS (ESI+) calculated for C15H18ClN3O2S 
[M+H]+ 340,0881, found 340.0887.  
 
4-((-3-(chloromethyl)-4-phenylpyrrolidin-1-yl)sulfonyl)-3,5-
dimethylisoxazole (4z). According to general procedure C1, 
isolated as a colorless oil (62.4 mg, 0.176 mmol, 88%) of a 
mixture of non separable diastereoisomers (dr = 72:28). Rf 0.53 
(25% EtOAc/hexane); 1H NMR (CDCl3) δ major diastereoisomer 
7.34 (q, J = 7.0 Hz, 2H), 7.30-7.28 (m, 1H), 7.20 (d, J = 7.0 Hz, 
2H), 3.76 (dd, J = 9.8, 7.0 Hz, 2H, H1, H4), 3.55 (dd, J = 11.4, 3.7 
Hz, 1H, H5), 3.42-3.37 (m, 2H, H1, H5), 3.34 (dd, J = 9.8, 9.0 Hz, 
1H, H4), 3.19 (td, J = 9.8, 8.1 Hz, 1H, H2), 2.73-2.71 (m, 1H, H3), 
2.67 (s, 3H), 2.45 (s, 3H); minor diastereoisomer 7.34 (q, 
J = 7.2 Hz, 2H), 7.30-7.28 (m, 1H), 7.16 (d, J = 7.0 Hz, 2H), 
3.72-3.68 (m, 2H, H1’, H4’), 3.67-3.64 (m, 1H, H1’), 3.62 (dt, 
J = 7.2, 3.5 Hz, 1H, H2’), 3.42-3.37 (m, 1H, H4’),3.14 (dd, 
J = 11.2, 5.7 Hz, 1H, H5’), 2.99 (dd, J = 11.2, 9.2 Hz, 1H, H5’), 
2.84-2.81 (m, 1H, H3’), 2.70 (s, 3H), 2.48 (s, 3H); 13C NMR 
(CDCl3) δ major diastereoisomer 173.6, 157.9, 137.8, 129.2, 
127.9, 127.4, 114.6, 54.1 (C1), 50.6 (C4), 47.9 (C3), 47.4 (C2), 
43.9 (C5), 13.0, 11.4; minor diastereoisomer 173.6, 157.8, 137.0, 
129.0, 127.7, 127.6, 114.9, 52.0 (C1’), 50.0 (C4’), 45.9 (C2’), 45.6 
(C3’), 43.1 (C5’), 13.0, 11.4; FTIR (νmax cm
-1) 2952 (sp3 C-H), 
2881 (sp3 C-H), 1360 (sulfone), 1175 (sulfone); HRMS (ESI+) 
calculated for C16H20ClN2O3S [M+H]
+ 355.0883, found 
355.0880. 
  
 
3-(chloro(phenyl)methylene)-4-phenyl-1-tosylpyrrolidine 
(4aa). According to general procedure C1, isolated as an off-
white solid (57.2 mg, 0.135 mmol, 68%) of a mixture of non 
separable isomers Z:E (85:15). With general procedure C2 
(60.2 mg, 0.142 mmol, 71%). Rf 0.50 (30% EtOAc/hexane); 
1H NMR (CDCl3) δ Z isomer 7.74 (d, J = 8.2 Hz, 2H), 7.39-7.33 
(m, 2H), 7.32-7.28 (m, 1H), 7.20-7.15 (m, 1H), 7.14-7.09 (m, 
4H), 7.03-6.99 (m, 2H), 6.90-6.87 (m, 2H), 4.31 (dd, J = 15.7, 
1.8 Hz, 1H, H4), 4.19 (d, J = 15.7 Hz, 1H, H4), 3.92-3.88 (m, 1H, 
H2), 3.56 (dd, J = 9.7, 7.0 Hz, 1H, H1), 3.47 (dd, J = 9.7, 3.5 Hz, 
1H, H1), 2.46 (s, 3H); E isomer 7.63 (d, J = 8.2 Hz, 2H), 7.39-
7.33 (m, 2H), 7.32-7.28 (m, 1H), 7.25-7.21 (m, 1H), 7.14-7.09 
(m, 4H), 6.95-6.92 (m, 2H), 6.85-6.81 (m, 2H), 4.23-4.20 (m, 1H, 
H2’), 4.15-4.12 (m, 1H, H4’), 3.94 (d, J = 14.5 Hz, 1H, H4’), 3.69 
(dd, J = 10.0, 7.5 Hz, 1H, H1’), 3.48-3.44 (m, 1H, H1’), 2.44 (s, 
3H); 13C NMR (CDCl3) δ Z isomer 143.9, 141.5, 137.3, 136.9, 
132.5, 129.8, 128.6, 128.5, 128.1, 128.0, 127.9, 127.2, 126.8, 57.2 
(C1), 53.4 (C4), 48.0 (C2), 21.6; E isomer 143.9, 141.0, 137.4, 
136.6, 132.6, 129.8, 128.7, 128.5, 128.0, 127.9, 127.8, 127.3, 
127.0, 55.2 (C1’), 52.2 (C4’), 49.0 (C2’), 21.6; FTIR (νmax cm
-1) 
2924 (sp3 C-H), 2848 (sp3 C-H), 1601 (C=C), 1343 (sulfone), 
1159 (sulfone); HRMS (ESI+) calculated for C24H22ClNO2SNa 
[M+Na]+ 446.0952, found 446.0953.  
 
4-(chloro(phenyl)methylene)-3-methyl-3-phenyl-1-tosyl 
pyrrolidine (4ab). According to general procedure C1, isolated 
as a white solid (63.0 mg, 0.144 mmol, 72%) as a single isomer Z. 
With general procedure C2 (60.4 mg, 0.138 mmol, 68%). Rf 0.46 
(30% EtOAc/hexane); 1H NMR (CDCl3) δ  7.72 (d, J = 8.0 Hz, 
2H), 7.37 (d, J = 8.0 Hz, 2H), 7.18-7.14 (m, 3H), 7.12 (t, J = 7.8 
Hz, 1H), 7.08-7.05 (m, 2H), 7.02 (t, J = 7.8 Hz, 2H), 6.81 (d, J = 
7.8 Hz, 2H), 4.32-4.23 (m, 2H, 2H4), 3.49 (d, J = 9.3 Hz, 1H, H1), 
3.25 (d, J = 9.3 Hz, 1H, H1), 2.48 (s, 3H), 1.30 (s, 3H, H6); 13C 
NMR (CDCl3) δ 144.8, 143.9, 142.2, 137.0, 131.9 (C
5), 129.8, 
128.6, 128.4, 128.2, 128.0, 127.7, 127.1 (C3), 126.7, 126.3, 65.1 
(C1), 54.7 (C4), 50.1 (C2), 23.7 (C6), 21.7; FTIR (νmax cm
-1) 2929 
(sp3 C-H), 2838 (sp3 C-H), 1601 (C=C), 1338 (sulfone), 1162 
(sulfone); HRMS (ESI+) calculated for C25H24ClNO2SNa 
[M+Na]+ 460.1109, found 460.1089; M.p.: 151-153 °C. 
 
4-(chloro(phenyl)methylene)-3-(4-methoxyphenyl)-2-methyl-
1-tosylpyrrolidine (4ac). According to general procedure C1, 
isolated as a yellow solid (70.8 mg, 0.151 mmol, 84%) of a 
mixture of non separable isomers Z:E (67:33). With general 
procedure C2 (65.2 mg, 0.139 mmol, 70%). Rf 0.36 (30% 
EtOAc/hexane); 1H NMR (CDCl3) δ Z isomer 7.55 (d, J = 8.2 Hz, 
2H), 7.40-7.35 (m, 2H), 7.23-7.10 (m, 5H), 6.63 (d, J = 8.7 Hz, 
2H), 6.57 (d, J = 8.7 Hz, 2H), 4.56 (d, J = 15.7 Hz, 1H, H4), 4.24-
4.17 (m, 1H, H4), 4.00-3.93 (m, 1H, H1), 3.76 (s, 3H, OMe), 3.52 
(br s, 1H, H2), 2.41 (s, 3H), 1.36 (d, J = 6.4 Hz, 3H, H6); E isomer 
7.57 (d, J = 8.2 Hz, 2H), 7.40-7.35 (m, 1H), 7.23-7.10 (m, 6H), 
6.82 (d, J = 8.7 Hz, 2H), 6.68 (d, J = 8.7 Hz, 2H), 4.24-4.17 (m, 
1H, H4’), 4.12 (dd, J = 14.5, 1.7 Hz, 1H, H4’), 4.00-3.93 (m, 2H, 
H1’, H2’), 3.78 (s, 3H, OMe), 2.41 (s, 3H), 1.46 (d, J = 6.4 Hz, 3H, 
H6’); 13C NMR (CDCl3) δ Z isomer 158.2, 143.1, 137.0, 136.4, 
133.6, 132.5 (C5), 129.4, 128.1, 128.0, 127.9, 127.8, 127.1, 113.9, 
129.0 (C3), 66.3 (C1), 55.1 (C2), 55.0 (OMe), 52.2 (C4), 21.9 (C6), 
21.4; E isomer 158.3, 143.4, 137.3, 135.7, 134.8, 132.5, 132.5 
(C5’), 129.6, 128.7, 128.5, 128.2 (C3’), 127.9, 127.8, 127.2, 114.0, 
64.3 (C1’), 56.5 (C2’), 55.2 (OMe), 51.4 (C4’), 22.7 (C6’), 21.5; 
FTIR (νmax cm
-1) 2927 (sp3 C-H), 2833 (sp3 C-H), 1596 (C=C), 
1341 (sulfone), 1242 (ether, C-O), 1159 (sulfone); HRMS (ESI+) 
calculated for C26H26ClNO3SNa [M+Na]
+ 490.1214, found 
490.1214.  
3-methyl-4-phenyl-1-tosyl-1H-pyrrole (5). In a microwave tube 
were placed the pyrrolidine 4a (79 mg, 0.23 mmol, 1 equiv.), 
KOH (127 mg, 2.26 mmol, 10 equiv.) and EtOH (2.2 mL, 0.1 M). 
The tube was sealed under an argon atmosphere and the reaction 
mixture was stirred at 80 °C for 18 h. The mixture was 
concentrated in vacuo. The residue was taken in H2O and the 
aqueous phase was extracted with CH2Cl2 (3x). The organic phase 
was dried over MgSO4, filtered and solvent was removed under 
reduced pressure. The crude was placed in a microwave tube and 
MnO2 (197 mg, 2.26 mmol, 10 equiv.) and toluene (2.2 mL, 0.1 
M) were added. The tube was sealed and stirred at 100 °C for 2 h. 
The mixture was filtered through a plug of celite. The filtrate was 
concentrated in vacuo. The crude was purified by silica flash 
column chromatography (95/5 to 9/1 hexane/EtOAc) to yield the 
desired pyrrole 5 as a clear orange oil (50.1 mg, 0.16 mmol, 
71%). Spectral data were in agreement with literature values.34  
 
3-(azidomethyl)-4-phenyl-1-tosylpyrrolidine (6). In a 
microwave tube was placed the pyrrolidine 4a (70 mg, 0.2 mmol, 
1 equiv.) in DMF (2 mL, 0.1 M). Sodium azide (65 mg, 1.0 mmol, 
5 equiv.) was added and the tude was sealed under an argon 
atmosphere. The reaction mixture was then stirred at 80 °C for 
18 h. The mixture was diluted in EtOAc and washed two times 
with 1N NaOH. The organic phase was dried over MgSO4, 
filtered and solvent was removed in vacuo. The crude was 
purified by silica flash column chromatography (9/1 to 8/2 
hexane/EtOAc) to yield the desired pyrrolidine 6 (colorless oil, 
51.7 mg, 0.15 mmol, 73%) as a mixture of non separable 
diastereoisomers (dr = 70:30). Rf 0.11 (10% EtOAc/hexane); 
1H NMR (CDCl3) δ major diastereoisomer 7.77 (d, J = 8.0 Hz, 
2H), 7.40-7.38 (m, 2H), 7.32-7.24 (m, 3H), 7.10 (d, J = 7.2 Hz, 
2H), 3.72 (dd, J = 10.2, 8.1 Hz, 1H, H1), 3.69-3.66 (m, 1H, H4), 
3.32-3.26 (m, 2H, H1 and H5), 3.19-3.16 (m, 1H, H4), 3.13 (dd, 
J = 12.5, 7.4 Hz, 1H, H5), 2.94 (q, J = 8.1 Hz, 1H, H2), 2.48 (s, 
3H), 2.40-2.34 (m, 1H, H3); minor diastereoisomer 7.81 (d, 
J = 8.0 Hz, 2H), 7.40-7.38 (m, 2H), 7.32-7.24 (m, 3H), 7.04 (d, 
J = 7.2 Hz, 2H), 3.69-3.65 (m, 1H, H1’), 3.63-3.59 (m, 1H, H1’), 
3.56 (dd, J = 10.5, 7.2 Hz, 1H, H4’), 3.47 (q, J = 6.6 Hz, 1H, H2’), 
3.32-3.26 (m, 1H, H4’), 2.88 (dd, J = 12.2, 6.1 Hz, 1H, H5’), 2.64 
(dd, J = 12.2, 8.9 Hz, 1H, H5’), 2.47 (s, 3H), 2.46-2.43 (m, 1H, 
H3’); 13C NMR (CDCl3) major diastereoisomer δ 143.8, 138.6, 
133.5, 129.8, 129.0, 127.6, 127.5, 127.3, 54.5 (C1), 51.6 (C5), 51.1 
(C4), 47.2 (C2), 45.9 (C3), 21.6; minor diastereoisomer 143.8, 
137.6, 133.7, 129.9, 128.8, 127.7, 127.5, 127.4, 52.2 (C1’), 50.4 
(C5’), 50.0 (C4’), 45.3 (C2’), 42.4 (C3’), 21.6; FTIR (νmax cm
-1) 
2924 (sp3 C-H), 2096 (sp3 C-H), 1341 (sulfone), 1159 (sulfone); 
HRMS (ESI+) calculated for C18H20N4O2SNa [M+Na]
+ 379.1197, 
found 379.1187.  
  
 
4-((4-phenyl-1-tosylpyrrolidin-3-yl)methyl)morpholine (7). In 
a microwave tube were placed the pyrrolidine 4a (70 mg, 
0.2 mmol, 1 equiv.), K2CO3 (276 mg, 2 mmol, 10 equiv.) and KI 
(7 mg, 0.04 mmol, 0.2 equiv.). Acetonitrile (2 mL, 0.1 M) was 
added and the tube was sealed under an argon atmosphere. The 
reaction mixture was stirred at 80 °C for 3 days. The crude was 
diluted with H2O and the aqueous phase was extracted with 
CH2Cl2 (3x). The organic phase was dried over MgSO4, filtered 
and solvent was removed in vacuo. The crude was purified by 
silica flash column chromatography (6/4 to 4/6 hexane/EtOAc) to 
yield the desired pyrrolidine 7 as a single diastereoisomer (white 
solid, 44.6 mg, 0.11 mmol, 56%). Rf 0.18 (50% EtOAc/hexane); 
1H NMR (CDCl3) δ 7.76 (d, J = 7.9 Hz, 2H), 7.36 (d, J = 7.9 Hz, 
2H), 7.28-7.25 (m, 2H), 7.24-7.20 (m, 1H), 7.08 (d, J = 7.4 Hz, 
2H), 3.70-3.63 (m, 2H, H1, H4), 3.58 (t, J = 4.9 Hz, 4H, H7), 3.26 
(t, J = 9.3 Hz, 1H, H1), 3.12 (dd, J = 10.2, 7.5 Hz, 1H, H4), 2.89 
(q, J = 8.4 Hz, 1H, H2), 2.47 (s, 3H), 2.41-2.36 (m, 1H, H3), 2.34-
2.28 (m, 2H, H5), 2.21-2.14 (m, 4H, H6); 13C NMR (CDCl3) δ 
143.5, 140.3, 133.6, 129.7, 128.7, 127.6, 127.3, 127.1, 66.8 (C7), 
61.0 (C6), 54.6 (C1), 53.7 (C5), 52.6 (C4), 48.5 (C2), 43.4 (C3), 
21.6; FTIR (νmax cm
-1) 2957 (sp3 C-H), 2891 (sp3 C-H), 2863 (sp3 
C-H), 2805 (sp3 C-H), 1338 (sulfone), 1116 (ether, C-O), 1157 
(sulfone); HRMS (ESI+) calculated for C22H29N2O3S [M+H]
+ 
401.1893, found 401.1897; M.p.: 137-139 °C. 
 
3-methyl-1-tosyl-1,2,8,8a-tetrahydroindeno[2,1-b]pyrrole (8). 
In a microwave tube were placed the pyrrolidine 4p (120 mg, 
0.33 mmol, 1 equiv.), KOH (185 mg, 3.3 mmol, 10 equiv.) and 
EtOH (3.3 mL, 0.1 M). The tube was sealed under argon and the 
reaction mixture was stirred at 80 °C for 18 h. The mixture was 
concentrated under reduced pressure. The residue was taken in 
H2O, and extracted with CH2Cl2 (3x). The organic phase was 
dried over MgSO4, filtered and solvent was removed in vacuo. 
The crude was purified by Florisil® flash column 
chromatography (95/5 to 85/15 hexane/EtOAc) to yield the 
desired product 8 (clear yellow solid, 101.4 mg, 0.31 mmol, 
94%). Rf 0.35 (20% EtOAc/hexane); 
1H NMR (CDCl3) δ 7.78 (d, 
J = 8.2 Hz, 2H), 7.36 (d, J = 8.2 Hz, 2H), 7.34-7.32 (m, 1H, H8), 
7.27-7.25 (m, 1H, H11), 7.22-7.20 (m, 2H, H9, H10), 4.69-4.63 (m, 
1H, H1), 4.30 (dd, J = 13.3, 4.3 Hz, 1H, H4), 4.24 (ddd, J = 13.3, 
4.3, 1.7 Hz, 1H, H4), 3.25 (dd, J = 15.3, 7.4 Hz, 1H, H6), 3.06 (dd, 
J = 15.3, 7.9 Hz, 1H, H6), 2.44 (s, 3H), 1.87 (s, 3H, H5); 13C NMR 
(CDCl3) δ 146.7, 143.7, 139.0, 134.1, 132.9, 129.8, 128.2, 128.1, 
127.1, 126.1, 123.0, 122.2, 71.7 (C1), 64.4 (C4), 38.1 (C6), 21.5, 
12.4 (C5); FTIR (νmax cm
-1) 2972 (sp3 C-H), 2929 (sp3 C-H), 2856 
(sp3 C-H), 1341 (sulfone), 1156 (sulfone); HRMS (ESI+) 
calculated for C19H20NO2S [M+H]
+ 326.1215; found 326.1205. 
M.p.: 158-160 °C. 
 
3-methyl-1-tosylindeno[2,1-b]pyrrol-8(1H)-one (9). In a 
microwave tube were placed the product 8 (20 mg, 0.06 mmol, 
1 equiv.) and MnO2 (26 mg, 0.3 mmol, 5 equiv.) in toluene 
(0.6 mL, 0.1 M). The tube was sealed and stirred at 100 °C for 6 h 
in total (every hour a new portion of 5 equiv. of MnO2 was 
added). The mixture was filtered through a plug of celite. The 
filtrate was concentrated in vacuo. The crude was purified by 
Florisil® flash column chromatography (95/5 to 9/1 
hexane/EtOAc) to yield the desired pyrrole 9 as an orange solid 
(9.4 mg, 0.03 mmol, 47%). Rf 0.25 (20% EtOAc/hexane); 
1H NMR (CDCl3) δ 8.05 (d, J = 8.2 Hz, 2H), 7.33-7.30 (m, 3H, 
H8), 7.21 (t, J = 7.5 Hz, 1H, H10), 7.18 (s, 1H, H4), 7.07 (t, 
J = 7.5 Hz, 1H, H9), 7.00 (d, J = 7.2 Hz, 1H, H11), 2.40 (s, 3H), 
2.16 (s, 3H, H5); 13C NMR (CDCl3) δ 178.4 (C
6), 148.2, 145.8, 
137.4, 136.6, 134.7, 133.1 (C10), 130.2, 130.0, 129.9 (C4), 128.0 
(C9), 127.9, 123.9 (C8), 119.5 (C11), 118.0 (C3), 21.7, 10.5 (C5); 
FTIR (νmax cm
-1), 2931 (sp3 C-H), 1697 (C=O), 1368 (sulfone), 
1177 (sulfone); HRMS (ESI+) calculated for C19H15NO3SNa 
[M+Na]+ 360.0665, found 360.0660; M.p.: 156-158 °C. 
 
4-((4-methoxyphenyl)(phenyl)methylene)-3-methyl-3-phenyl-
1-tosylpyrrolidine (10). In a microwave tube were placed the 
pyrrolidine 4ac (100 mg, 0.23 mmol, 1 equiv.), 4-methoxyphenyl 
boronic acid (140 mg, 0.92 mmol, 4 equiv.), PdCl2(P(o-tol)3)2 
(18 mg, 0.023 mmol, 0.1 equiv.) and Cs2CO3 (450 mg, 
1.38 mmol, 6 equiv.) in toluene (0.5 mL, 0.4 M). The tube was 
sealed under an argon atmosphere and stirred at 110 °C for 18 h. 
The mixture was diluted in EtOAc and filtered through a plug of 
celite. The filtrate was concentrated in vacuo. The crude was 
purified by silica flash column chromatography (9/1 to 8/2 
hexane/EtOAc) to yield the desired pyrrolidine 10 as a yellow oil 
(92.1 mg, 0.18 mmol, 78%). Rf 0.25 (20% EtOAc/hexane); 
1H NMR (CDCl3) δ 7.62 (d, J = 8.0 Hz, 2H), 7.33 (d, J = 8.0 Hz, 
2H), 7.16-7.14 (m, 3H), 7.12-7.10 (m, 2H), 7.02 (d, J = 8.7 Hz, 
2H), 6.98 (t, J = 7.4 Hz, 1H), 6.92 (t, J = 7.4 Hz, 2H), 6.82 (d, 
J = 8.7 Hz, 2H), 6.61 (d, J = 7.4 Hz, 2H), 4.06-4.01 (m, 2H, 2H4), 
3.79 (s, 3H, OMe), 3.41 (d, J = 9.3 Hz, 1H, H1), 3.17 (d, 
J = 9.3 Hz, 1H, H1), 2.47 (s, 3H), 1.33 (s, 3H, H6); 13C NMR 
(CDCl3) δ 158.4, 146.5, 143.6, 141.6, 140.4, 137.4, 135.1, 132.3, 
129.6, 128.8, 128.7, 128.0, 127.9, 127.3, 126.4, 126.2, 126.1, 64.8 
(C1), 55.2 (OMe), 53.6 (C4), 49.5 (C2), 24.3 (C6), 21.6; FTIR (νmax 
cm-1) 2926 (sp3 C-H), 2838 (sp3 C-H), 1606 (C=C), 1343 
(sulfone), 1248 (ether C-O), 1157 (sulfone); HRMS (ESI+) 
calculated for C32H31NO3SNa [M+Na]
+ 532.1917, found 
532.1894. 
 
4-benzyl-3-methyl-3-phenyl-1-tosylpyrrolidine (11). In a 
conical flask was placed the pyrrolidine 4ac (40 mg, 0.09 mmol) 
in MeOH/CH2Cl2 1:1 (0.05 M). The mixture was passed on a 
H-Cube apparatus through a cartridge of Pd/C 10% (0.5 mL/min, 
60 °C, 60 bars) until complete conversion was observed by mass 
analysis. The crude was concentrated in vacuo and purified by 
silica flash column chromatography (85/15 to 8/2 hexane/EtOAc) 
to yield the pyrrolidine 11 as a mixture of two diastereoisomers 
dr = 86:14 (colorless oil, 26.4 mg, 0.065 mmol, 72 %). Rf 0.46 
(30% EtOAc/hexane); ); 1H NMR (CDCl3) δ major 
diastereoisomer 7.75 (d, J = 8.0 Hz, 2H), 7.35 (d, J = 8.0 Hz, 
2H), 7.32-7.30 (m, 2H), 7.25-7.15 (m, 6H), 6.84 (d, J = 7.3 Hz, 
2H), 3.85 (d, J = 9.5 Hz, 1H, H1), 3.49 (d, J = 9.5 Hz, 1H, H1), 
3.41 (dd, J = 10.3, 6.6 Hz, 1H, H4), 3.12 (dd, J = 10.3, 5.5 Hz, 1H, 
H4), 2.50-2.47 (m, 1H, H5), 2.46 (s, 3H), 2.30-2.25 (m, 1H, H3), 
1.56-1.52 (m, H5), 1.33 (s, 3H, H6); minor diastereoisomer 7.69 
(d, J = 8.0 Hz, 2H), 7.35 (d, J = 8.0 Hz, 2H), 7.32-7.30 (m, 3H), 
7.25-7.15 (m, 5H), 7.00 (d, J = 7.3 Hz, 2H), 3.47-3.43 (m, 2H, 
H1’), 3.44-3.39 (m, 1H, H4’), 3.17 (t, J = 9.8 Hz, 1H, H4’), 2.67-
  
2.62 (m, 2H, H3’, H5’), 2.45 (s, 3H), 2.36-2.31 (m, 1H, H5’), 1.24 
(s, 3H, H6’); 13C NMR (CDCl3) δ major diastereoisomer 143.4, 
143.3, 139.8, 134.5, 129.7, 128.6, 128.5, 128.4, 127.4, 126.6, 
126.5, 126.2, 58.0 (C1), 50.8 (C4), 50.2 (C3), 48.6 (C2), 35.3 (C5), 
27.5 (C6), 21.6; minor diastereoisomer 143.6, 143.3, 139.8, 134.4, 
129.7, 128.6, 128.3, 127.3, 126.8, 126.3, 125.9, 61.8 (C1’), 51.6 
(C4’), 49.9 (C3’), 47.4 (C2’), 34.0 (C5’), 29.7 (C6’), 19.3; FTIR (νmax 
cm-1) 2927 (sp3 C-H), 2886 (sp3 C-H), 1341 (sulfone), 1154 
(sulfone); HRMS (ESI+) calculated for C25H27NO2SNa [M+Na]
+ 
428.1654, found 428.1643.  
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